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Aqueous two-phase systems (ATPS) are a quirk of thermodynamics, wherein two 
immiscible solutions separate into stable liquid phases, containing primarily water. 
Conveniently, some biomolecules partition favorably into one phase or the other. Recently, 
these properties have been used for many applications, including micropatterning, 
purification, target concentration, and reagent segregation.  
In this work, we examined a previously under-appreciated property of ATPSs – the 
spontaneous generation of circulating fluid flow with ATPS micro-droplets. First, we 
developed and validated a novel imaging modality, stigmatic microscopy, to perform the 
first 3D measurements of ATPS micro-droplet self-driven circulation. This technique 
borrows concepts from super-resolution microscopy to identify the 3D positions of 
fluorescent microbeads from individual image frames. Specifically, the use of a toroidal 
lens shifts the x-focal plane apart from the y-focal plane, enabling determination of z-
position from the point-spread function of the image. We designed the microscope using 
optical modeling to determine usable lens strengths and distances. After constructing the 
microscope, we developed software to determine 3D positions of fluorescent micro-beads 
and link the positions from time frame to time frame to track flow. 
Second, we enhanced the performance of an ATPS multiplex immunoassay. In 
previous work from our lab, antibody pairs are spotted in ATPS micro-droplets to co-
localize them, preventing crosstalk between incorrect antibody pairs. We advanced this 
assay from a manually spotted method to a pre-dried format, wherein one phase of the 
ATPS is rehydrated by the other. We demonstrated that antibody segregation is 
maintained throughout the rehydration process. With further consideration of self-driven 
flow, we reduced assay incubation time drastically, first in a two-wash format and 
subsequently in a one-wash format. Further examination of the competing ATPS 
xvi 
 
parameters identified an optimal medium between viscosity, partition behavior, and 
convective flow.  
Third, we extended another ATPS bioassay from our lab – collagen microgel 
contraction to facilitate research on pulmonary fibrosis, a deadly disease with no effective 
treatments. The collagen gel contraction assay is a helpful measurement of the wound 
healing activity of fibroblasts. However, current formats use large numbers of cells, 
restricting their use with primary lung fibroblast cells, which have limited growth capacity. 
To address the issue, our lab previously used ATPS to generate microscale bioprinted 
collagen gels and demonstrated proof-of-concept with cell lines. However, the behavior of 
primary cells proved more difficult to study, due to small effect sizes. To overcome this 
obstacle, we incorporated higher throughput and use continuous imaging (as opposed to 
end point assays). This yielded a markedly more reliable assay, which we used to observe 
the effects of current and potential therapeutics. Notably, we identify differences between 






CHAPTER 1: Stigmatic microscopy enables low-cost, 3D, microscale particle 
imaging velocimetry in rehydrating aqueous two-phase systems 
 
1.1 INTRODUCTION 
Aqueous two-phase systems (ATPS) can form when immiscible polymers are 
mixed in water. In these systems, many cells and biomolecules partition preferentially 
and predictably into one phase or the other (10). These characteristics enable 
separation and compartmentalization of biomolecules (11-13). ATPS-assisted 
immunoassays have harnessed these characteristics to address several emerging 
applications such as reagent delivery to cells (14), bacterial patterning (15), and 
sensing (16), and selective immuno-staining of cells (17). They have been designed 
using dehydrated reagents, which initiate the assay upon rehydration (18, 19). The 
rehydration process of ATPS droplets may dictate reagent mixing and influence the 
overall assay performance (20, 21). However, the dynamic behavior of the convection 
in and out-of-equilibrium in ATPS rehydrating micro-droplets has been difficult to 
measure (22, 23). Due to this, many ATPS-assisted applications remain in the nascent 
development phase, lacking consensus design principles. The ability to measure 
internal convective flow would prove important in the process of forming these 
principles, thereby enabling many applications to mature.  
Flow tracking approaches have been explored for other applications such as 
particle image velocimetry (PIV), optical coherence tomography (OCT) and confocal 
microscopy. PIV has been utilized to deduce the trajectory of a 2d flow by tracking 
beads within the flow as they are scanned using a light sheet (24). Two-camera PIV 
further enables 3D tracking, though it is somewhat limited by the necessary multiple 
viewing angles. At higher resolution, µPIV has been integrated into microscopy 
systems, but it requires an additional prism system to enable 3D tracking (25). OCT 
measures the back scattering of coherent light to produce high resolution 3D images 
(21, 26). Confocal microscopy can produce high resolution 3D images, but the z-
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scanning method requires long image acquisition times (27). Spinning disk confocal 
has somewhat reduced that time. These techniques have all produced remarkable 
advances in many fields, however it would be attractive to collect 3D information about 
flow dynamics from a single image on a simple, low-cost laboratory setup.  
To address this need we have developed a microscopy technique called 
stigmatic microscopy which separates the sagittal and tangential focal planes. This is 
achieved by introducing an astigmatism into the microscopy system. This concept was 
first proposed by Huang et al. who utilized it to improve reconstruction in super-
resolution microscopy (28). We proposed that the optical concept could be adapted at 
a lower magnification and combined with three-dimensional flow tracking software to 
study and optimize the flow dynamics in ATPS rehydrating droplets for ATPS-based 
applications. Here we present the design and validation of the stigmatic microscope, 
then describe our insights into the flow dynamics of rehydrating ATPS droplets and 
finally apply this technique to illustrate flow dynamics in a cell exclusion assay (29) and 
a fast enzyme-linked immunosorbent assay (ELISA) system that we have previously 
demonstrated for multiplex readouts (19).  
1.2 MATERIALS AND METHODS 
1.2.1 Modeling stigmatic microscope parameters 
As introduced before, it would be attractive to measure the convective mixing 
inside of a rehydrating droplet in real time. This would enable the indirect measurement 
of the forces in the droplet that drive convective rehydration. These forces cannot 
currently be measured. Here we introduce stigmatic microscopy, a microscopy 
technique in which astigmatic aberrations in the imaging system are used to determine 
the vertical position of an object relative to the focal plane (Figure 1.1A). When 
combined with bead tracking in the x- and y- directions, we can track a bead in three-
dimensions as it is carried by flow inside a droplet.  
Astigmatism occurs when an oblique bundle of rays impinges a lens that does 
not have a symmetrical front (30). The resulting image appears foreshortened in the 
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plane of incidence (tangential plane) and elongated in the sagittal plane. The difference 
between the image points in the tangential and sagittal planes is the astigmatic 
difference or the aberration called astigmatism. If the astigmatic difference is large, 
then the image of a bead will appear elongated in the sagittal plane above the focal 
plane and elongated in the tangential plane below the focal plane. Here we 
demonstrate that by designing an infinity corrected microscope with a prescribed 
astigmatism, we can derive a relationship between the position of the bead in the z 
direction relative to the x-y focal plane and the image of the bead.  
Most modern microscopes are designed using an infinity corrected design (30). 
This term implies that the objective projects the bundle of rays it has imaged as parallel 
rays. In an ideal system, these would travel to infinity if not for the tube lens, which 
focuses these rays onto an eye piece or camera (charge-coupled device (CCD), 
complementary metal-oxide semiconductor (CMOS), or other). To convert an infinity 
corrected design into a stigmatic microscope, a toroidal lens is inserted between the 
objective and the tube lens (Figure 1.1A). Because a toroidal lens has different focal 
lengths in the sagittal and tangential directions, it will introduce an astigmatism into the 
final image.  
As shown in Figure A.1.1A, the paraxial layout establishes the focal lengths 
and overall size of the microscope. The lens system is composed of two lens groups, 
the objective (Nikon 4X CFI Achromat, NA 0.1) and tube lens (Thorlabs, LJ1516RM), 
with a stop in between them and an entrance pupil (20 mm) controlled by the objective. 
There is also a doublet relay lens (Thorlabs, AC254-050-A) to alter the magnification 
of the image onto the camera. Here f1 is the focal length of the objective, f2 is the 
distance between the tube lens and the relay lens, f3 is the distance between the relay 
lens and the camera, and d is the distance between the objective and the tube lens. 
They are arranged such that the objective is one focal length (50 mm) away from the 
substrate and the camera is 86.7 mm away from the tube lens. Without the relay lens 
this distance would be one tube lens focal length (154 mm). To introduce astigmatism, 
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a half round toroidal lens was inserted into the system 3 mm in front of the tube lens 
and the system was re-focused using the root mean square (RMS) centroid spot size 
(49.7 mm). These elements were used as the basis of our idealized model of the optical 
system. 
The paraxial model of the microscope was developed in the optical design 
software ZEMAX (31). It is important to note that some prescriptions of optical 
components used in experiments are proprietarily held by Nikon and data on them is 
unavailable, so the model presented here is for an idealized infinity corrected 
microscope. As an example of the contribution to astigmatism by the toroidal lens, 
Figure 1.1B shows the shape of a bead above and below the focal plane when a 1000 
mm toroidal lens is used. We demonstrate how the strength of the toroidal lens can be 
mapped to the distance between the best focus for the sagittal and tangential directions 
(Figures A.1.1D, A.1.1E). This data is necessary to calibrate the microbead z-position 






Figure 1.1. Stigmatic microscopy design and model. (A) Diagram showing microscope 
components. Adapted from Huang 2008 Science. (B) ZEMAX model of stigmatic 
control under microscope design for two fields (0.00, 0.57) (C) Confirmation of stigmatic 
imaging on a 3 µm bead when the bead is between -100 µm and 100 µm above and 
below the focal plane of the microscope. 
 
 
1.2.2 Constructing stigmatic microscope 
For our test microscope, we adapted an inverted Nikon TS100 microscope by 
inserting off the shelf components from Thorlabs (TTL, a 200 mm tube lens and 
LJ1703RM, a 1000 mm toroidal lens) as guided by the model. The focal length of the 
tube lens was chosen to match the Nikon 200 mm focal lengths specified by the 
company. The microscope was constructed by unthreading the Nikon tube lens and 
replacing it with the Thorlabs toroidal and tube lenses respectively. The toroidal lens 
was placed 3 mm in front of the tube lens. Note that the rotational alignment of the 
toroidal lens with the camera is critical for subsequent analysis.  
1.2.3 Calibrating microbead z position 
To calibrate the microbead z position from a captured image we measured the 
astigmatic aberration using an algorithm in Python and the library OpenCV (Figure 
1.2A) (32). A single 3 µm yellow-green fluorescent bead was placed in a 96-well plastic 
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microplate inside a droplet and allowed to settle to the bottom of the well (Figure 1.2B). 
Images were taken at 5.5 µm intervals from -200 µm below the bead to 200 µm above 
the bead, then fed into the software algorithm.  
The z-calibration loop collected particle height and width for each image, then 
appended the particle dimensions to an array labeled by z-stack position, as follows. 
For each image, a threshold was used to generate a binary image. From the binary 
image, a bounding ellipse was fit to the bead dimensions to find the center of the bead 
using the built-in functions in OpenCV (33). The particle was found using blob detection 
and a region of interest (ROI) was used to extract just the particle from the image, as 
depicted in Figure 1.2B. A line histogram was applied along the x and y axes of the 
image to project the 2D point spread function of the bead. A spline was fit to the full 
width at half maximum (FWHM) of the data. The line histogram data was filtered to 
only include lines two sigma from the mean to filter noise. The distance between the 
roots of the spline provided the width and height of the bead. This algorithm enables 
simultaneous detection of multiple beads at multiple z heights from the same image 




Figure 1.2. Calibration of the microscope. (A) The algorithm used to calibrate the 
microscope. (B) The point spread function (measured and fit) of a bead. (C) The bead 
dimensions plotted against the focus position (z) and the final calibrated relationship.  
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This same technique was applied after imaging at intervals above and below 
the focal plane to produce a scatter plot of the width and height of the bead at different 
z positions. The result of fitting a spline to this data is the calibrated relationship of the 
point-spread function (PSF) of the bead to its position relative to the focal plane of the 
objective. The z position of an unknown bead can then be calculated using a least-
squares fit on the calibrated relationship, which attempts to minimize the error between 
both the width and height of the bead to the calibrated model. Note that the least-
squares fit on the spline function is somewhat sensitive to initial z estimate, so we pre-
filtered the z estimate by fitted ellipse area and by width to height ratio. Finally, we plot 
the measured z-position of several beads to the known z-position of those beads that 
were back calculated, as shown in Figure 1.2C.  
1.2.4 Preparation of DEX – PEG aqueous two-phase systems 
Two aqueous two-phase systems were selected, based on prior experience in 
ATPS micropatterning. Our group has previous published work on the multiplex ELISA 
and cell exclusion assay using polyethylene glycol (PEG) (MW 35,000, Sigma) and 
dextran (DEX) (MW 500,000, Sigma) (18, 29). Flows in a PEG and Ficoll (MW 400,000, 
Sigma) system were also examined. We generated phase diagrams for both systems 
using a conventional dilution method (34). Briefly, we prepared concentrated polymer 
solutions in phosphate buffered saline (PBS) (20 % w/w polymer) and mixed the 
biphasic solutions in a range of different volume ratios. The resulting cloudy mixtures 
(two-phase) were diluted by a PBS solution until the binodal point where the mixtures 
turned transparent (one-phase). A univariate spline was fit to the resulting set of points 
to indicate the binodal curve (34). Separate solutions above the tie-line were prepared 
to measure the resulting top phase/bottom phase volume ratio. Using the conservation 
of mass, the volume ratio can be calculated from the ratio of distances between the 
bulk concentration and either intersection of the tie-line with the binodal curve. Tie-
lines were fit to the phase diagram using a custom Python script. A least-squares fit 
was used to find the slope of the tie-line that matched the volume ratio calculated by 
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the relative tie-line lengths to the measured volume ratio. The intersection of the tie-
line with the binodal curve was found by least-squares fitting between the binodal 
spline and the tie-line with a fitted slope that passed through the bulk concentration 
point. Note that the univariate spline does not accurately describe the binodal curve at 
near-zero values of the independent variable, so an inverse spline was also found and 
used for the opposite end of the binodal curve, i.e. y(x) for low values of y and x(y) for 
low values of x. Phase diagrams are included in Figure A.1.2.  
We measured convection in rehydrating ATPS that mimics the situation seen 
in the multiplex immunoassay format (18, 19) and cell exclusion patterning (29). 
Solutions of the DEX phase in deionized-water were spotted in 1 µL droplets in a clear, 
flat-bottom 96-well microplate with 3 µm yellow-green fluorescent polystyrene beads 
(polysciences), diluted to approximately 10-20 particles per µL. The plates were dried 
in a vacuum desiccator overnight prior to rehydration. DEX microdroplets were 
rehydrated on the stigmatic microscope with indicated concentrations of PEG in PBS 
and imaged over indicated times. For flow exclusion studies, beads were diluted to 10-
20 particles per μL in the PEG-rich phase to track flow outside of the rehydrating 
droplet.  
1.2.5 Flow tracking 
Time course images were collected using Nikon NIS Elements and saved as 
16-bit .nd2 files. These files were converted to 8-bit .tiff images, conserving the low 
intensity region of the data using a FIJI macro. We wrote analysis in Python to calculate 





Figure 1.3. Algorithm for measuring droplet rehydration dynamics in stigmatic 
microscopy. The process for measurement involved rehydrating the drop under 
microscopic imaging, during which the particles were tracked, and their X, Y and Z 




The image thresholding and bead position calculation followed the same 
algorithm as in the calibration protocol. For each period t, several bead positions were 
calculated and indexed. Each existing bead was then compared to beads in frame t+1 
and linked to the nearest neighbor by x, y, z distance in microns, checking against a 
maximum travel distance threshold. If a match was found, that bead pair was removed 
from subsequent matching to prevent flow traces from artificially merging. The 
remaining beads from period t were similarly matched to the remaining beads in frame 
t+1. Any beads that were not matched were held for five time frames before terminating 
that bead path. The resulting flow trace matrix contained x, y, z positions, time points, 
and bead identity indices. Traces containing fewer than five hundred time points were 
eliminated as noise.  
For flow exclusion studies, the field of view was aligned to contain the outer 
edge of the droplet. To view the flow at the droplet interface, a 400 pixel (600 μm) slice 
was taken by filtering the trace data in the y-dimension. The traces were then projected 
to the x-z plane. Flow traces originating within the general droplet area, defined as a 
rectangle in the bottom right corner of the x-z plot, were marked as "inside" and 
pseudo-colored blue. All other traces were pseudo-colored red.  
Flow traces were imported to MATLAB and smoothed using a Loess filter in x, 
y, and z. Once smoothed, the time derivative of 3D distance traveled could be 
calculated numerically to find particle speed. For the 15-minute traces, the root-mean-
square of the speed was calculated for each particle to find a general metric for mixing 
efficiency. To distinguish between the fast mixing eddy regions and the larger central 
flow, flow traces were plotted in a 3D interactive diagram using open-source plotly 
functions, color-coded by time, and examined for annotation. To determine droplet 
rehydration height, traces were examined in the interactive plots, as well as using x-z 
projections.  
1.2.6 Cell Exclusion 
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Cell exclusion assays were performed by rehydrating 1 μL DEX drops in which 
the PEG phase also contained MDA-MB-231 cells (ATCC) to observe if the DEX 
spotting would exclude the cells from adhering to the spotted region. Three conditions 
were studied, including a 2.5% PEG-6.4% DEX (w/w) ATPS system, a 2.5% (w/w) 
PEG only system and Dulbecco’s Modified Eagle’s Medium (DMEM) system. The DEX 
was prepared first at 6.4% (w/w) in DMEM F12 (Invitrogen) labelled with fluorescein 
isothiocyanate (FITC)-DEX (0.1% w/w, Sigma). Each solution was filtered (0.22 µm 
polyvinylidene fluoride (PVDF) syringe filter) in a sterile environment after the reagents 
had been prepared and dissolved. The 2.5% PEG-6.4% DEX system was pre-
equilibrated by centrifugation at 25oC, 3000 rotations per minute (rpm) for 15 minutes, 
and the top phase was extracted for cell exclusion experiments. 
 The DEX solution was spotted in 1 µL drops into clear, flat-bottom 96-well 
tissue culture microplate using an Integra Biosciences Viaflo 96-well pipetting robot 
(pipet function, speed 8 with a Z height of 11.2 for the receiving plate) and were dried 
overnight in the incubator to maintain sterility. The top phase of the 2.5% PEG-6.4% 
DEX solution or the 2.5% PEG only or DMEM solutions were prepared in DMEM F12 
as described above. Cells were resuspended in these solutions at a concentration of 
400,000 cells/mL, then added to the dried DEX spot plate to rehydrate the DEX. The 
cells were stained with NucBlue Live (Thermofisher) according to the manufacturers 
protocol. The plates were incubated for 2 hrs at 37 °C to allow cell settling, then 
imaged.  
1.2.7 ATPS ELISA 
The current work adapts the protocol from our group’s previous publication (19) 
using a human interleukin (IL)-8 DuoSet kit (R&D Systems). ELISAs were performed 
in custom 96-well injection molded plates with 1.7 mm diameter microbasins (9 per 
well) (Xcentric Mold & Engineering). Plates were washed with ethanol and distilled 
water, then dried overnight in a desiccator. Capture antibody (cAb) solutions at the 
manufacturer recommended concentration in PBS (4 μg/mL) were applied in 1 μL 
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spots to the microbasins. The plates were sealed and incubated for 90 min to allow 
adsorption. Free capture antibody was then washed 3x using 200 μL wash buffer 
(0.05% Tween 20 in PBS), followed by addition of 100 µL of 5% sucrose (Sigma) in 
PBS for 1 hour to block unused surfaces. The sucrose was emptied, and the plates 
were dried in a vacuum desiccator for 40 minutes. Once dry, 5% bovine serum albumin 
(BSA) in PBS was spotted 1 μL per microbasin on top of the IL-8 cAb spots to further 
block reaction surfaces. The BSA was dried in the vacuum desiccator for 40 min. 
Detection antibody (dAb) was mixed in solutions of 5% (w/w) DEX MW 500,000 in 
water (Sigma). These dAb solutions were then spotted 1 μL per microbasin and dried 
in a vacuum desiccator overnight.  
To run the assay, IL-8 standards from the kit were diluted in an assay buffer 
consisting of 5% (w/w) or 10% (w/w) PEG glycol MW 35,000 (Sigma), 0.05% Tween 
20 (Sigma), and 0.5% BSA (Sigma) in PBS (Gibco). An 8-point standard curve was 
generated with 2-fold dilutions from 2,000 pg/mL in quadruplicate. To avoid biasing the 
plate by sample addition order in the fast ELISA, samples were loaded onto a feeder 
plate in a randomized plate layout. The samples were then simultaneously transferred 
from the feeder plate to the assay plate using the Viaflo 96-well robotic pipet. The 
assay was initiated upon addition of the PEG-sample solutions, which immediately 
began to rehydrate the dried DEX and antibody reagents. Samples and standards were 
incubated in the dark at room temperature for 15 minutes. The plates were washed 6 
times with wash buffer to clear out the viscous ATPS components. Streptavidin-horse 
radish peroxidase (HRP) conjugate (R&D Systems) was added at the manufacturer’s 
recommended concentration and incubated for 20 min. Plates were washed 3x, then 
filled with SuperSignal ELISA Femto Maximum Sensitivity Substrate (ThermoFisher) 
and the plates were imaged using a BioRad ChemiDoc MP+ chemiluminescent blot 
reader.  
ELISA plate images were analyzed using a custom ImageJ plugin to outline 
microbasin regions and calculate chemiluminescent intensity. The standard curve was 
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plotted using the ggplot2 library in CRAN-R. Analysis of variance (ANOVA) was used 
to test effects of row, column, ATPS condition, and IL-8 concentration in a randomized 
plate design with a confidence interval of 95%. Following ANOVA, a posthoc Tukey 
test was performed with a 95% confidence interval. A linear model was used to fit the 
data and remove effects from row and column location within the plate to plot the 
standard curve.  
1.3 RESULTS & DISCUSSION 
1.3.1 Stigmatic microscope validation 
Z-stacks from an individual fluorescent bead indicated that the stigmatic 
microscope transformed the PSF as expected (Figure 1.2B, Figure A.1.1B). Figure 
1.1B shows sample images taken along a stack of z positions, where the spread of 
light follows the shape predicted in the spot diagram. The 3 μm bead diameter 
corresponds to 2 pixels in image-space, making it a reasonable approximation for a 
PSF. Smaller beads were also examined, but the tradeoff between fluorescent 
intensity and size led to the selection of the 3 μm bead. The 3 μm beads are expected 
to respond to gravitational force for sedimentation (35) and other forces for convection 
(36). Generally, smaller beads will be less sensitive to gravitational effects and 
therefore better for flow tracking. However, small beads contain less dye and have low 
fluorescent intensity, requiring longer exposure times to capture the shape of the PSF. 
Exposure can be further tuned to sacrifice depth of field for imaging frequency. For 
applications examining shallower flows, smaller beads may still be appropriate. In this 
work, a 500 ms exposure provided sufficient detail about the shape of the PSF to detect 
z-position within at least the calibrated 400 μm range. Faster flows requiring shorter 
exposure can be detected by decreasing the exposure time and sacrificing z-range or 
by introducing a photo-multiplier tube into the system.  
After performing the calibration outlined in Figures 1.2A, 1.2B on 3 different 
beads, the images were fed back into the z-retrieval algorithm to recover z-position. 
Figure 1.2C indicates accurate recovery of the z-position.  
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1.3.2 Rehydration dynamics of rehydrating ATPS droplets 
Three primary types of flow dynamics emerged during the rehydration process 
(Figure 1.4A). The first was the volcano current, in which direction of flow is up the 
center of the droplet. The second is the inverse volcano, in which the current flows 
down the center of the droplet. We also observed transient micro eddies in high mixing 
regions where particles would rapidly rotate near the bottom, outer edge of a droplet.  
Volcano currents were observed in Ficoll-based ATPS drops while both 
volcano and inverse volcano currents were observed in DEX-based ATPS drops, 
depending on specific ATPS composition. Interestingly, the micro eddies were only 
present in the DEX ATPS drops. Figures 1.4B, 1.4C show an example of a DEX-driven 
inverse volcano. Fig 1.4B shows the isometric view of particles being tracked in the 
droplet over fifty minutes. Fig 1.4C shows the side view of the same droplet in which 
individual beads show a uniform current around the drop. This is just an example of 
the measurements that are observed using the stigmatic microscope system.  
For many applications, knowing the velocity of the current and the cycling rate 
of the fluid in the drop may be useful for optimizing conditions. Fig 1.4D shows an 
example of the flow dynamics of a bead in the fluid. The z position of the bead in this 
example increases in both amplitude and period with time. Moreover, the velocity of 
the bead shows a double peak pattern after reaching the peak of the drop. The 
maximum z-position the particle reaches increases with time in this case from 50 µm 
to 75 µm, and it is inversely proportional to the maximum velocity per flow cycle, as the 
droplet becomes more well-mixed and loses some of the chemical potential gradient 





Figure 1.4. Flow dynamics and rates of rehydrating ATPS droplets. (A) Examples of 
observed flows inside of rehydrating ATPS droplets. (B) 3D plot showing the flow 
dynamics of an exemplary rehydrating Ficoll-rich droplet. (C) 2D slice of the center of 
the same Ficoll drop over several flow cycles. (D) Dynamics and rate of rehydration as 
measured for a drop showing particle positions over time (red) and particle velocity 




1.3.3 Cell Exclusion 
The correlation between flow behavior and rehydrated ATPS cell exclusion 
patterning was examined. Previously reported experiments indicated a change in cell 
exclusion efficiency depending on the composition of the ATPS. Therefore, three 
ATPS conditions were tested (Figure 1.5A): 1 – the extracted top phase from the 2.5% 
PEG-6.4% DEX system, 2 – a sub-critical ATPS, made of 2.5% PEG, and 3 – cell 
culture media alone. Note that the sub-critical ATPS contains a small overall 
concentration of DEX from the dried 1 μL DEX spot. However, that overall 
concentration of DEX (0.064%) does not bring the total system above the binodal 
curve. For imaging, the field of view was shifted to include the edge of the droplet to 
see flow behavior at that region of interest during rehydration, as indicated in Figure 
1.5B.  
Visual examination of the flow both inside and outside of the droplet added new 
explanation to the success of cell exclusion patterning. In the two-phase condition, flow 
tracking within and around the rehydrating droplet indicates a volcano-pattern 
circulation within the droplet, and a downward/outward flow in the surrounding media 
(Fig 1.5B). This generates a small stagnant zone at the center of the droplet, which 
corresponds to the typical location of cells that evade exclusion and attach near the 
center of the droplet (29). This experiment indicates that convective flow is present and 
may help drive cell seeding away from the droplet, in addition to the previously 
hypothesized interfacial exclusion.  
In sub-critical ATPS, there is a transient flow exclusion for ~1 hour, while the 
DEX-rich phase is at a transient, locally high concentration. Over time, the DEX may 
be diffusing into the bulk phase while the DEX-rich phase is also diluted by infiltrating 
osmosis, reducing the local concentration below the binodal curve. Temporal analysis 
of the convective flow paths shows that after ~1 hour, beads settle through the area 
previously obstructed by the temporary phase boundary. In the absence of PEG, flow 





Figure 1.5. Effect of rehydration dynamics on cell exclusion. (A) ATPS solutions 
indicated by red Xs were used to rehydrate DEX droplets, shown prior to rehydration 
in panel (B). (B) Flow traces, labeled by trace starting position (inside blue, outside 
red) were measured and 3D sections indicated by the yellow box were projected to the 
X-Z plane. (C) Cell exclusion was imaged two hours after seeding MDA-MB-231 
cancer cells using phase contrast (top) and fluorescent imaging with FITC-labeled DEX 




The efficacy of cell exclusion correlates with the flow profiles (Figure 1.5C). 
Representative brightfield and fluorescence images indicate near total cell exclusion 
in the two-phase condition, but no noticeable exclusion in the sub-critical ATPS or the 
media-only control. The lack of cell exclusion in the sub-critical ATPS result indicates 
either that convection alone was insufficient to direct cell patterning, or that cell settling 
continued to occur beyond the 1 hour of transient exclusion flow.  
The difference between the pre-equilibrated two-phase condition and the sub-
critical ATPS emphasizes the need for clarity in ATPS research when communicating 
ATPS concentrations, particularly near the critical point. Some papers describe the 
overall concentration (mid-tie-line, as in this experiment), while others describe the 
resulting phases used along the binodal curve.  
1.3.4 ATPS ELISA 
The impact of ATPS composition on ELISA performance could arise from a 
variety of factors. These include partition behavior, volume ratio, convective mixing, 
and viscous limitations on diffusion. The partition coefficient and volume ratio 
determine the concentrating effect from ATPS (37). Partition coefficients and volume 
ratios further from unity cause higher concentrations of reagents into one phase, in this 
case the DEX phase. Techniques already exist to determine partition coefficients, 
volume ratios, and viscosity, but internal convective mixing has been difficult to 
measure.  
The stigmatic microscope presented here can add missing information 
regarding convective mixing and transient volume ratio in non-equilibrium ATPS. We 
examine two ATPS conditions, with low or high PEG concentrations (5% or 10% w/w, 
respectively) to rehydrate a dried 1 μL droplet of 5% DEX, for overall ATPS consisting 
of 5% PEG and 0.05% DEX or 10% PEG and 0.05% DEX. We will refer to these 
conditions as 5% PEG-5% DEX and 10% PEG-5% DEX, respectively. Recent work 
suggests that convection in non-equilibrium ATPS is driven by a chemical potential 
gradient (23). The chemical potential gradient is higher for the higher concentration 
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PEG, which lies on a longer tie-line. However, the resulting concentrations of PEG and 
DEX in the top and bottom phases are also higher, leading to higher viscosity and 
associated drag on convective flow.  
 
 
Figure 1.6. Effect of rehydration dynamics on ELISA performance between 5% PEG – 
5% DEX (pink) and 10% PEG – 5% DEX (red). (A) Individual speed traces were 
summarized using their root-mean-square (RMS) values, then plotted in boxplots. 
*Significant at 95% confidence interval. (B) The standard curve for the row-column-
corrected IL-8 ELISA was determined. The difference in signal intensity between 5% 
PEG-5% DEX and 10% PEG-5% DEX was statistically significant at 95% confidence 
interval by ANOVA with a posthoc Tukey test.  
 
 
We quantified spontaneous convective mixing in rehydrating ATPSs. As 
depicted in Figure 1.4D, flow traces were smoothed in x-, y-, and z- dimensions as 
functions of time for numerical differentiation to find the speed over time. Speed was 
then quantified using the RMS velocity to summarize each flow trace into a single 
measurement. The flow traces were visually examined to annotate each trace as a 
short eddy or a larger, center flow. The RMS speeds were analyzed between 
conditions using ANOVA, followed by a posthoc Tukey test at a 95% confidence 
interval. The center flow was significantly faster for the 5% PEG-5% DEX compared to 
the 10% PEG-5% DEX, while the difference between eddies did not meet the 95% 
confidence interval (Figure 1.6A). We suggest that the additional drag effects from 
viscosity in the 10% PEG-5% DEX condition seem to outweigh its higher chemical 
potential gradient driving forces.  
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Overall droplet height was roughly identical for the 5% PEG and 10% PEG 
conditions (Figure A.1.3). The indistinguishable droplet heights do indicate that 
potential differences in volume ratio between ATPS conditions are not present. 
Therefore, differences in ELISA signal may be attributed primarily to differences in 
convective mixing.  
The extensive mixing effect seen in the 5% PEG condition correlated with 
higher signal intensity in the standard curve of a rehydrated ATPS ELISA for human 
IL-8. ANOVA with posthoc Tukey test indicated significant that the 5% PEG-5% DEX 
condition gave higher intensity than 10% PEG-5%DEX at a 95% confidence interval. 
The row-column corrected standard curve is shown in Figure 1.6C. We suggest that 
this result occurs because greater internal convection provides more binding 
opportunities between the detection antibodies confined within the DEX droplet and 
the IL-8 sample in the bulk PEG-rich phase. The convection also allows additional 
binding opportunities for the IL-8 sample to the capture antibody on the microplate 
surface.  
Furthermore, we have shown an ELISA with only a 15-minute incubation, 16 
times faster than our previously reported protocol (10). This study demonstrates the 
ability to measure convective mixing using stigmatic microscopy, which will be critical 
for further analysis and optimization of this short incubation ELISA. These studies will 
include analysis of other ATPSs and their impact on signal intensity and variation.  
1.4 CONCLUSION 
The design of the microscope is both simple and flexible, enabling it to be 
integrated into most off the shelf microscope systems without a deep knowledge of 
optics. The principle is that a weak cylindrical or toroidal lens (1000 mm or greater) will 
introduce enough astigmatism to enable stigmatic microscopy but will not interfere 
significantly with the imaging performance of the system. This provides complementary 
advantages over other methods (PIV, OCT, Confocal) in that the temporal detail is only 
limited by the exposure time of a single image. With our particular microscope system, 
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this worked for 500 ms exposures, but shorter exposures should be possible with a 
photo-multiplier tube or more sensitive camera. Moreover, because no scanning of a 
laser or light sheet is necessary, the rate of capture may ultimately be much faster.  
The results shown for both ELISA and cell exclusion demonstrate that insights 
into the performance of ATPS driven assays can be captured using stigmatic 
microscopy. In ELISA, we found that viscous effects outweigh driving forces, while cell 
exclusion was found to be controlled by choosing either a critical or sub-critical ATPS 
condition. Moreover, we demonstrated immunoassay incubation times 16x faster than 
those previously demonstrated by our group.  
Future work will further explore the application of stigmatic microscopy to 
multiplexed ELISA and will enable the derivation of complete flow fields of the droplet 
over time. We also believe additional work will enable accurate detection of the droplet 
shape and morphological changes as required by new applications.  
In conclusion, we present a stigmatic microscope designed to enable facile 
measurement of convective mixing both inside and outside of ATPS droplets. The 
specific observations as well as general methodology should aid in the development 
of design principles for various ATPS applications. The ability to conveniently image 
3D flows in the µm-mm regime is also envisioned to be useful in understanding the 
forces and dynamics that drive a number of microfluidic and droplet-based systems 
beyond ATPS systems.  
Chapter adapted from Yamanishi C, Oliver CR, Kojima T, Takayama S. 
Stigmatic Microscopy Enables Low-Cost, 3D, Microscale Particle Imaging Velocimetry 
in Rehydrating Aqueous Two-Phase Systems. Front Chem. 2019;7:311 under the 




CHAPTER 2: Systems for multiplexing homogeneous immunoassays 
 
2.1 Introduction to multiplex homogeneous immunoassays 
The National Institute of Health defined protein biomarkers as “key molecular 
or cellular events that link a specific environmental exposure to a health outcome.” 
Understanding the interactions of multiple protein biomarkers of disease will play an 
integral role in drug screening, in biological pathway analysis, and in disease diagnosis 
(38). Single-analyte detection has provided high accuracy results, but in a limited 
scope. Multiplex detection methods, i.e. measurement and analysis of multiple 
biomarkers together, provide a view of the entire system. Current protein biomarker 
discovery techniques use mass spectrometry on pooled patient samples, because it 
provides high-throughput results (39). However, validation of biomarker targets and 
clinical diagnoses are performed using sandwich immunoassays, due to their high 
sensitivity and specificity (40). Discrepancies between the two techniques and general 
challenges associated with performing large scale clinical validations limit the 
translation of discovered targets to clinical practice (41), resulting in fewer than 2 new 
protein biomarkers approved by the Food and Drug Administration (FDA) per year (42). 
Therefore, reliable multiplex immunoassays are needed. 
Due to their high sensitivity, specificity, and procedural convenience, this article 
will focus on homogeneous sandwich immunoassays. Sandwich immunoassays come 
in two formats: heterogeneous and homogeneous. The standard ELISA is 
heterogeneous, with cAb immobilized onto a microtiter plate. The addition of dAb forms 
the antibody-antigen-antibody sandwich complex (43). The requirement for both the 
cAbs and dAbs to bind to the target reduces noise from non-specific binding (44), 
making the sandwich format more specific than label-free methods (45-52), which only 
use one antibody. Unlike heterogeneous immunoassays, homogeneous sandwich 
immunoassays use both the cAb and the dAb in solution, typically conjugated to an 
identifiable (encoded) marker. Binding in solution, rather than at a surface, drastically 
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reduces the distance that antigens must diffuse to reach the antibodies. Combined with 
the elimination of washing steps, this reduces assay time, making homogeneous 
assays more suitable for biosensors and assays used in field applications. Additionally, 
the absence of washing steps allows antibodies with relatively low affinity to be used, 
because unbinding events do not result in loss of antigens. The soluble format can 
also provide a more native reaction environment for the antibodies than the surface-
bound format, as proteins have been shown to undergo conformational changes when 
they adsorb to non-native surfaces (53). Most homogenous sandwich immunoassays 
to date, however, have a major limitation. Because both capture and detection antibody 
reagents are freely diffusing in solution, it has been difficult to perform spatially 
segregated reagent multiplexing when performing homogenous immunoassays. The 
goal of this article is to review the latest methods and techniques to overcome this 
limitation to enable multiplex homogenous sandwich immunoassays.  
Bead-based systems fit in between heterogeneous and homogeneous. These 
assays replace the planar surface of standard ELISA with microbeads, encoded with 
identifiers. Bead assays still have faster mixing than standard ELISA, because 
diffusion time scales as , where L is the characteristic length and D is the 
diffusivity; the characteristic length between particles in solution is much smaller than 
the length between the bulk solution and the surface. However, large beads diffuse 
more slowly than free antibodies. The Stokes-Einstein relation describes the diffusivity 
as inversely proportional to radius at constant temperature and viscosity. 
Immunoglobulin G (IgG) antibodies have radius ~5 nm (54). Adding a bead 1 µm in 
diameter will therefore reduce the diffusivity by 100-fold.  
For the purpose of this review, we strictly define homogeneous immunoassays 
as those containing all antibodies and antigens in solution, with no washing between 
antibody-antigen binding steps. This definition will exclude pseudo-homogeneous 
bead-based assay formats, such as the Luminex xMAP system, which employs 
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suspension microbeads as a solid phase replacement for planar surfaces (Bead 
sources). The Luminex system retains some of the assay time advantages of 
homogeneous systems, but the wash step precludes low affinity antibodies from being 
used in assays. This is not a problem for biomarkers with well-established antibody 
libraries, but finding high affinity antibodies for obscure or recently discovered proteins 
can be difficult. Our selection criteria also exclude microfluidic platforms despite their 
capacity for automation of washing steps or their shared advantages with 
homogeneous sandwich immunoassays, including reduced diffusion distances and 
small sample volume consumption (55-58).  
 
 
Figure 2.1. Quantitative ranges for homogeneous multiplex assays, compiled from 
various sources: Troponin I fluorescence polarization immunoassay (FPIA) (59), 
Flourescence resonance energy transfer (FRET) (60), Proximity (61), and luminescent 
oxygen-channeling immunoassay (LOCI) from Perkin-Elmer’s website; IL-6 FRET from 
Cisbio Assays’ website, Proximity (62), and LOCI from Perkin-Elmer’s website. 
 
In this report, we primarily review techniques for multiplexing homogeneous 
sandwich immunoassays, highlighting the merits and demerits of each. Fluorescent 
polarization immunoassay employs only the cAb but is included in this scope due to 
the fact that it is an established and commercially available homogeneous assay. 
Without performing cross-platform comparison experiments in the same lab, 
evaluating parameters such as sensitivity and dynamic range can be inconsistent; 
immunoassay performance depends heavily on user skill and sample handling (63). 
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However, even comparisons between different labs can provide general metrics of an 
assay. To normalize as much as possible, we compare assay performance for the 
same protein targets: troponin I and IL-6, as shown in Figure 2.1.  
2.2. Homogeneous multiplex sandwich immunoassay formats 
2.2.1. Fluorescence polarization immunoassay 
Fluorescence polarization immunoassay (FPIA) is a form of competitive 
immunoassay. When incident light excites a fluorescently tagged stationary molecule, 
the resulting emission will be on the same polarized plane as the light source. 
Conversely, light from a rotating fluorescent molecule will be emitted in a rotated plane. 
In a free floating solution, large molecules experience less rotation and motion during 
excitation, and will therefore give off a smaller depolarization whereas small molecules 
will have larger depolarization. As fluorescent target molecules bind with the antibody, 
the difference in depolarization can be measured. The immunoassay uses antibodies 
alongside fluorescently labeled antigen, also known as. tracer. When the tracer binds 
with antibodies, the whole fluorophore complex is stabilized, thereby reducing motion 
and allowing for greater polarized emission (64-66). When test samples such as patient 
plasma or serum are introduced to the system, the patient’s target antigen will compete 
with tracer molecules for the antibodies. The technique is by nature homogenous and 
compatible with automated detection for high-throughput analysis. However, it is 
limited to small molecule applications because more dramatic changes in 






Figure 2.2. Fluorescence polarization immunoassay (FPIA). (A) Polarization intensity 
in relation to molecule complex size and rotation speed. Figure adapted by author from 
(66) (B) Schematic representation of multiplex fluorescence polarization adapted by 
author from (67). 
 
Multiplex FPIA can be achieved by utilizing multicolor quantum dots with narrow 
emission bandwidths that can be cleanly resolved. This format uses the same principle 
as single-plex FPIA, wherein the antibody stabilizes the quantum dot to polarize the 
light. Specifically, a two-plex assay was designed with red and green quantum dots 
conjugated with tumor biomarkers. The target protein can be identified by the color of 
the quantum dot, as shown in Figure 2.2. In this method, centrifugation with 
ultracentrifuge filters of serum samples prior to the assay was necessary to remove 
matrix proteins to reduce matrix interference. The results of this multiplex assay were 
shown to have clinical diagnostic value comparable to commercial ELISA (67).  




Figure 2.3. Fluorescence resonance energy transfer (FRET) (A) Resonance energy 
transfer between donor and acceptor (B) FRET applied to immunochemistry. Figure 
adapted by author from (68). 
 
Fluorescence resonance energy transfer (FRET) based immunoassays utilize 
a donor-acceptor system, as illustrated in Figure 2.3. When a laser excites the donor 
fluorophores, the resultant fluorescent energy is transferred from the donor fluorophore 
to the nearby acceptor molecule, which will subsequently release photons of a different 
wavelength for detection. The donor and acceptor molecules are both attached to 
antibodies specific to the target protein. If the target is present, the antibodies can form 
sandwich complexes with the target, keeping their respective donor and acceptor tags 
in close proximity. Because the efficiency of energy transfer decreases rapidly as the 
distance between the donor and acceptor pair increases, the fluorescent signal 
corresponds to the presence of the target. However, this distance dependence also 
limits the sensitivity of sandwich immunoassays, due to the relatively large distance 
across the antibodies and antigens in a sandwich complex (69). 
Considerable progress has been made to improve FRET efficiency. The 
important parameters for FRET efficiency are the quantum yield, extinction 
coefficients, and spectral overlap (68). The quantum yield and extinction coefficients 
of both the donor and the acceptor should be high to maximize efficiency. Using 
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genetic engineering of fluorescent proteins, donor-acceptor pairs can be tuned with 
large overlap between donor emission and acceptor absorption spectra to increase 
energy transfer efficiency. On the other hand, undesirable overlap between the donor 
emission and acceptor emission spectra can be minimized to avoid optical crosstalk. 
Although FRET based assays are traditionally built with fluorescent dyes, 
current research on FRET based immunoassays is dominated by nanostructures 
made up of nanorods, nanoshells, and quantum dots. These nanostructures make use 
of the surface plasmon resonance effect to increase FRET signal for higher detection 
sensitivities. Zhang et al. engineered a quantum dot and gold nanorod two-plex assay 
to maximize FRET yield (70). Gold nanorods have two distinct plasmon resonances, 
corresponding to their two dimensions, longitudinal and transverse. Because both 
dimensions are tunable, gold nanorods are ideal acceptors for multiplex assays. Two 
different sizes of quantum dots (Cadmium Telluride/Cadmium sulfide core/shell) with 
two different emission wavelengths were tailored to maximize the overlap of quantum 
dot donor emission and self-assembled gold nanorods acceptor absorption spectra. 
This system exhibited high specificity between the two targets, indicating the utility of 
the FRET pairs in the multiplex system.  
2.2.3. Fluorescent Quantum Dots-Graphene Immunoassay 
Graphene quenching provides an alternative to FRET. Graphene sheets 
efficiently quench fluorescence from quantum dots when the two are in close proximity. 
Therefore, in contrast to FRET, a decrease in fluorescence corresponds to presence 
of targets in the sample. The primary disadvantage of assays based on energy transfer 
between quantum dots and nanostructure systems lies in the required donor and 
acceptor dipole-dipole distance which is limited to 10-100 Å (69). However, graphene 
sheets are shown to overcome this restriction (71). Compared to a quantum dot-
quantum dot pair, the two-dimensional graphene sheets have more possible spatial 
arrangements in which parts of the sheet are close enough to the spherical quantum 
30 
 
dots to cause quenching, as seen in Figure 2.4. This platform increased the effective 
distance between the quantum dot anchor and the grapheme anchor from 100 Å up to 
223 Å. This distance increase enables greater sensitivity in the sandwich assay 
formats that use the antigen as a bridge to bring the dAb-coated quantum dot close to 
the cAb-coated graphene surface.  
 
 
Figure 2.4 Quantum dots and graphene sheets sensor utilizing the fluorescence 
quenching ability of the graphene sheets to overcome distance dependent limitation of 
energy transfer techniques. Figure adapted by author from (71). 
 
 
2.2.4. Luminescent Oxygen-Channeling Immunoassay 
The luminescent oxygen channeling immunoassay (LOCI), commercially 
available as AlphaLISA, from PerkinElmer, uses donor and acceptor beads (250-350 
nm diameter) (72). When the donor beads are excited by 680 nm light, they release 
reactive singlet oxygen. This activated singlet oxygen decays back to its ground state 
quickly in solution. However, if acceptor beads are nearby, the singlet oxygen 
molecules can transfer their energy to the chemiluminescent compound in the acceptor 
beads, triggering the acceptor beads to emit light at 615 (72), as depicted in Figure 
2.5. In a sandwich assay format, capture antibodies attached to acceptor beads bind 
to target proteins in solution. Biotinylated detection antibodies sandwich the target 
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proteins. Streptavidin-coated donor beads then bind to the detection antibodies to 
complete the complex. The presence of the target protein thus determines how many 
donor-acceptor pairs are in close proximity, where they can produce the 
chemiluminescent signal. The LOCI can perform two-color multiplex immunoassays 
using a second acceptor bead that is also excited by singlet oxygen and emits at 545 
nm. The second donor bead is functionalized with the appropriate antibodies, but 
contains the same light-sensitive compound as the first donor bead.  
The LOCI format is fairly convenient for bench-top research. LOCI assays can 
be read using a microplate reader equipped with the proper fluorescent channels. For 
these readers, high laser power is recommended for optimal signal. Additionally, the 
LOCI format has intrinsic advantages for accuracy. Because LOCI employs a shift from 
a high wavelength excitation to a lower wavelength emission, it eliminates noise from 
autofluorescence. Compared to the other optical detection assays, the AlphaLISA 
assay has a relatively wide dynamic range and low limit of detection for the detection 
of IL-6 and troponin I, as shown in Figure 2.1. 
 
 
Figure 2.5. Luminescent oxygen-channeling immunoassay (LOCI). In the LOCI format, 
donor beads are excited by 680 nm light and release singlet oxygen. Acceptor beads 
in the vicinity emit 615 nm light in response to the singlet oxygen. Figure adapted by 
author from (73). 
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Although the commercially-available PerkinElmer system is currently limited to 
two-plex using chemiluminescence at two different emission wavelengths, higher 
multiplexing has been demonstrated by spatially arraying reagent solutions using 
ATPS (74). When two immiscible polymers are mixed in an aqueous solution at 
appropriate concentrations, they cause separation of the resulting aqueous solution 
into two phases. These systems are mild to biomolecules, making them appropriate 
for use in immunoassays. In a PEG-DEX ATPS, antibodies and beads partition 
preferentially into the dextran phase, allowing spatial confinement of different 
AlphaLISA bead pairs within different phase-separated droplets within a single well, as 
demonstrated in Figure 2.6.  
The ATPS reagent localization strategy marks a promising development for 
multiplex assays. The technique is theoretically compatible with other homogeneous 
immunoassay formats that have not yet been multiplexed, including simple bead 
agglutination. Additionally, the spatial localization eliminates the possibility of crosstalk 
between unmatched antibody pairs. Therefore, assay validation does not require the 
extensive combinatorial screening that many other multiplex techniques must undergo. 
However, the ATPS method has some drawbacks. The polymers involved are viscous, 
lowering the diffusivity of reagents and requiring slightly longer assay time. This 
method also requires specialty plates with topographical features within each well to 
position the reagent microdroplets from moving within the well. The published 4-plex 
AlphaLISA assay plate was designed to be compatible with conventional 1536 well 





Figure 2.6. ATPS ELISA colocalizes donor-acceptor pairs within dextran (DEX) 
microdroplets, enabling spatially distinct multiplex detection with a single color. Figure 
adapted by author from (74). 
 
2.2.5. DNA Proximity 
Proximity multiplex formats use deoxyribonucleic acid (DNA) oligomers to 
encode antibodies. Taking advantage of existing DNA sequencing techniques, the 
proximity extension assay (PEA) (62) uses antibody pairs attached to DNA 
oligonucleotides. As shown in Figure 2.7, when the antibodies sandwich the target 
protein, the DNA oligonucleotides come into close proximity, where the DNA strand 
from one antibody can hybridize with its complementary DNA strand on the partner 
antibody. This hybridization allows a DNA polymerase to extend the DNA at both ends. 
The resulting oligonucleotides can be subsequently amplified by quantitative 
polymerase chain reaction (qPCR). Only the completed DNA strands, i.e. those which 
had hybridized and been extended by the DNA polymerase, can be amplified by PCR. 
Thus, DNA detected by qPCR reflects the presence of the target protein. In multiplex 
PEA, distinct DNA sequences are used to identify each antibody pair. The PEA 
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Figure 2.7. DNA proximity assays (A) The proximity extension assay uses antibodies 
with oligonucleotides in a sandwich format. (B) DNA strands are hybridized with nearby 
complementary strands. (C-E) Through qPCR, dNA hybridization can be quantified. 
Reprinted under the Creative Commons Attribution license from (62) (c) 2014 
Assarsson et al. 
 
In a similar format to PEA, the PLA (75, 76) also uses DNA oligomers to encode 
antibody pairs. Whereas the DNA oligomers in PEA are complementary to each other, 
the DNA oligomers in PLA do not hybridize with each other. Rather, a third DNA 
oligomer is added to the solution to bridge the DNA on the antibody pair. To increase 
the specificity of the assay, one study attached an antibody to the third DNA oligomer 
(77). 
Proximity multiplex immunoassays provide an additional level of protection 
against cross-reactions because both of the antibodies in the pair contain specific 
labels, unlike AlphaLISA, which uses the same type of donor bead for both acceptor 
beads. The proximity immunoassays, however, contain specific oligonucleotides on 
both the capture and the detection antibodies. Therefore, both specific antibodies must 
be present to generate a signal. For IL-6, the proximity extension assay has a limit of 
detection of 0.12 pg/mL. Although Olink offers a 96-plex cardiovascular disease panel, 
troponin I is not included. However, the proximity ligation assay has been 
demonstrated to have a limit of detection of 0.4 pM for troponin I. The accuracy 
advantages of DNA proximity assays come at the cost of increased assay time and 
complexity. The 96-plex assay required an overnight sample incubation, followed by 
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DNA hybridization and the qPCR steps. The Olink company has addressed many of 
the added steps by incorporating their qPCR process into the Fluidigm automated 
microfluidic PCR reader, the BioMark HD. 
2.3. Assay validation 
Before implementation, new immunoassays must be validated for their 
analytical performance, then for clinical validation (78). Such is true for singleplex 
assays, but there are even more considerations that a multiplex assay must take into 
account. Potential cross-reactions between both endogenous and exogenous 
antibodies and proteins may result in over- and under-estimation of protein 
concentrations and should be screened out. Polyclonal antibodies that are multivalent 
can compensate for low affinities, but the high specificity of monoclonal antibodies are 
preferred for reduced crosstalk (79-82). Validation for multiplex assays often involved 
comparisons with its singleplex counterparts for quality references, but for high number 
multiplex, other analytical methods, such as batch sampling, have to be employed (44, 
62). Intra-assay variability, matching wide dynamic ranges and limit of detections also 
required careful investigations (83, 84). 
Another important consideration for immunoassays is matrix interference. 
Matrix interference refers to the effect resulted from all sample components had on the 
analytical quality. This effect can be observed by dilutions of samples with different 
dilution factor and diluents. Investigation of minimum dilution factor is necessary to 
avoid quantification errors (85-87). This is especially true in no-wash sandwich 
immunoassays, where the hook effect, or prozone phenomenon occurs (88). As higher 
concentrations are measured, the signal will increase, plateau, then decrease in a hook 
shape. The decrease results from target proteins saturating both the detection 
antibodies and the capture antibodies, preventing formation of the sandwich complex. 
The hook effect may be addressed by diluting the sample into the monotonic range of 
the assay (89). Alternatively, Weinstock et al. have demonstrated that addition of 
eythylenediaminetetraacetic acid (EDTA) to serum can reduce the hook effect, by 
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inhibiting the activity of calcium-dependent matrix proteins, such as the complement 
system (90). 
Multiplex immunoassays are particularly susceptible to false positives arising 
from cross-reactivity (91). Cross reaction can occur in several different ways: antibody-
antibody, antibody-antigen, and antigen-antigen. In single-plex ELISAs, antibody pairs 
are carefully screened and selected, but the number of necessary tests rapidly 
increases with plexing. Juncker and coworkers performed a combinatorial analysis of 
possible cross reacting pairs in a sandwich multiplex format (44), and found that the 
number of liable pairs scales as 4N(N-1), in an N-plex assay. Although these types of 
reactions may be rigorously screened and eliminated, the upper limit of screening at 
reasonable cost has been estimated at 50 (92). To address cross-reactivity in planar 
arrays, aqueous two-phase systems have been employed to confine detection 
antibody solutions to the volume directly above their corresponding capture site (74). 
Some patient samples contain human heterophilic antibodies, i.e. antibodies 
that bind to many of the animal IgGs used in immunoassays (93). These heterophilic 
antibodies interfere with the immunoassay to cause non-linearity. Classically, this is 
detected by measuring serial dilutions to check for linearity. However, protections from 
heterophilic antibody interference can be built into the assay. These measures include 
PEG precipitation (94), specialized antibodies (95), and blocking additives (94). 
2.4. Conclusion 
In this review, we described the principles and state-of-the-art of multiplexing 
homogeneous sandwich immunoassays: methods of encoding and quantification for 
FRET, AlphaLISA, and DNA proximity assays. We discussed the need for multiplexing 
to increase throughput of immunoassays for biological studies and disease diagnosis, 
as well as the advantages multiplexing provides in sample and reagent consumption. 
On the other hand, we also acknowledged some of the remaining challenges in the 
field of multiplex immunoassays: high-throughput validation, matrix interference, cross-
reactivity, and some of the workarounds to address these issues. The growing field of 
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multiplex immunoassays offers many promising methods for high-throughput protein 
screening, and we expect multiplex immunoassays to assume a significant role in 
biology and healthcare. 
 Chapter adapted from Bioanalysis. (2015) 7(12), 1545-1556 with permission of 






CHAPTER 3: Aqueous two-phase system rehydration of antibody-polymer 
microarrays enables convenient compartmentalized multiplex immunoassays 
 
3.1. Introduction 
In multiplex immunoassays, the requirement for reliable reaction 
compartmentalization often conflicts with the need for convenient sample and reagent 
dispensing at the point-of-use. Many conventional planar (96-98), bead-based (98-
100), and microfluidic (101) multiplex immunoassays resort to bath application of 
cocktails of all dAb reagents to provide convenience at the cost of higher background 
signals from potential antibody cross-reactions. Indeed, this disadvantage complicates 
assay validation procedures and hinders multiplex ELISA from becoming more widely 
used in clinical settings (78, 91, 102). Water-in-oil droplet systems (103), slip chips 
(104), colocalization arrays (105), tape array technology , and some microfluidic 
platforms (106, 107) provide reliable reaction compartmentalization, but require special 
devices and unconventional, and often inconvenient, sample and reagent handling 
procedures because these systems are actually performing multiple singleplex 
reactions. 
Recently, the use of water-in-water biphasic systems was demonstrated as a 
way to compartmentalize immunoassay reagents without using physical walls (18, 74). 
However, the procedure required tedious dispensing of individual droplets containing 
detection antibody reagents during the assay at the point-of-use (a 4-plex assay in a 
96-well format would require 384 pipetting steps from the user for dAb application 
alone). Here, we describe a microwell-based multiplex immunoassay where cAb is 
immobilized and dAb reagents, together with an ATPS-forming polymer, are 
prearrayed in their dried state. To perform the assay, samples are diluted in a solution 
containing a second ATPS-forming polymer and are added to prespotted microwells. 
The sample solution rehydrates each reagent spot to autonomously form an array of 
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water-in-water droplets. After washing away unbound reagents, microwells are ready 
for signal readout. 
Figure 3.1A illustrates the successful phase separation of a solution including 
PEG (clear solution) and DEX (blue solution). In Figure 3.1B, this concept of in-well 
prearraying and storage of dried reagents in DEX (blue spots, top), as well as 
convenient autonomous formation of compartmentalized water-in-water droplet arrays 
upon sample solution addition (blue droplets, bottom left), is demonstrated. Notably, 
reagents and reactions are compartmentalized within each droplet (containment of 
blue reagent) when ATPS-forming PEG diluent is used (bottom left), but not in its 
absence (bottom right). The PEG-DEX system was chosen for use with our assay 
platform because it is well-studied for a variety of separation and purification 
applications and provides a gentle and stabilizing environment for biological materials 
(108, 109). Factors influencing the distribution of the different materials are, among 
others, size and hydrophobicity. As determined by Frampton et al. and Simon et al., 
the partitioning coefficients for both their protein antigens and antibodies in this water-
in-water droplet array system favor the DEX phase (18, 74). This partitioning behavior 
enables a multiplex ATPS ELISA limiting unwanted dAb interactions during the length 
of an assay. Additionally, a report from Lee et al. using time-lapse optical coherence 
tomography to monitor PEG-DEX ATPS droplet rehydration showed that rehydration 




Figure 3.1. Phase separation and rehydration of dried reagent spots to form an array 
of water-in-water droplets. In a 1.5 mL microtube, a mixture of 9% PEG and 1.5% blue 
DEX separates into a top (clear PEG) and bottom phase (blue DEX) (A). On a 32-well 
microplate, blue DEX was arrayed at the bottom of two wells and dried overnight in 
desiccant (B, top). A solution containing the ATPS-forming polymer PEG was added 
to the left well which rehydrated the DEX spots and retained the blue DEX in droplets 
(B, bottom left). The right well was filled with PBS only and was unable to form an 
ATPS, resulting in a uniform blue color (B, bottom right). 
 
The prespotting of both cAb and dAb required for sandwich assays, together 
with the ATPS-forming and reagent-stabilizing DEX, provides a robust multiplex 
immunoassay that reduces unwanted antibody cross-reactions and saves expensive 
assay reagents. Additionally, end-users are provided a significant convenience 
through the reduction of pipetting steps. The utility of this platform is demonstrated 
through quantitative analysis of cytokine [IL-1β, IL-6, IL-8, IL-10, and tumor necrosis 
factor (TNF)-α] secretions from lipopolysaccharide (LPS)-stimulated ThP-1 cells. The 
monocytic cell line ThP-1 is a commonly used model system for studying systemic 
inflammatory response that can differentiate into a macrophage-like state (110, 111). 
3.2. Materials and methods 
3.2.1. Reagents 
All antibodies, protein standards, and streptavidin-HRP were purchased from 
R&D Systems (human IL-1β DuoSet DY201, human IL-6 DuoSet DY206, human IL-8 
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DY208, human IL-10 DY217B, and human TNF-α DY210). Chemiluminescence 
substrate (SuperSignal ELISA Femto Maximum Sensitivity Substrate) was acquired 
from Thermo Fisher Scientific. Buffers and other reagents were mixed in-house from 
bulk containers of PBS pH 7.4 (Gibco, Life Technologies, 10010-049), ultrapure 
distilled water (DNase and RNase free, Invitrogen, Life Technologies, 10977-023), 5× 
StabilCoat immunoassay stabilizer (SurModics), d-sorbitol (Sigma), dextran (DEX, MW 
500 000 g/mol, Pharmacosmos), poly(ethylene glycol) (PEG, MW 35 000 g/mol, 
Aldrich), Tween 20 (Sigma), and BSA (Fraction V, Fatty-Acid Free, Nuclease and 
Protease Free, CalBiochem, Millipore). 
3.2.2. Multiplex Assay Plate Preparation Procedure 
All experiments were performed using custom-designed, 32-well clear 
polystyrene plates (Figure A.3.1A). Well layout and spacing was based on 96-well 
microplate standards from the Society for Laboratory Automation and Screening 
(SLAS). A 32-well design was chosen to reduce costs for initial method development 
and proof of concept work. In this design, each well bottom contains nine microbasins 
in a 3 × 3 array (0.35 mm depth and 1.7 mm diameter) that assist with droplet 
segregation during assays. Additionally, having fixed droplet locations (and analysis 
regions) facilitates data analysis by keeping spot alignment consistent from well to well 
and across plates. 
Prior to immobilization, cAb stocks were diluted to working concentrations in 
PBS. Determination of optimal cAb concentrations is described in the Results and 
Discussion section. For antibody immobilization, 1 μL of each cAb solution was placed 
in a different microbasin for each well (Figure A.3.1B). Plates were then sealed and 
incubated in the dark for 90 min. After incubation, 0.5 μL droplets of 3× StabilCoat 
(diluted from 5× stock with distilled water) were deposited onto all existing cAb 
droplets. Plates were then placed under a fan to dry for 20 minutes. After dehydration 
of the cAb/StabilCoat mixture, 1 μL droplets of a solution containing 5% sorbitol and 
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15% DEX in PBS were placed in every microbasin containing cAb. After this addition, 
plates were placed under a fan for another 30 min for a second dehydration step. A 
final microbasin coating consisted of 0.5 μL droplets of a solution containing detection 
antibody at working concentration (IL-1β, 200 ng/mL; IL-6, 50 ng/mL; IL-8, 20 ng/mL; 
IL-10, 75 ng/mL; TNF-α, 400 ng/mL), 10% sorbitol, and 16.67% DEX in 1.67× 
StabilCoat. Finished plates were stored in a desiccator before use the following day. 
All liquid deposition steps were performed with either an electronic pipet (Repeater 
Stream, Eppendorf) for 1 μL volumes, or a Hamilton syringe (25 μL, model 1702RN, 
7654-01) for 0.5 μL volumes. Hamilton syringes were equipped with PB600-1 
repeating dispensers (Hamilton, 83700) and 1-in., 26s gauge small hub removable 
needles (Hamilton, 8646-02). 
3.2.3. Cell Culture and Supernatant Preparation 
Human monocytic ThP-1 cells, a gift from Dr. Peter Ward, University of 
Michigan, Ann Arbor, were grown in Roswell Park Memorial Institute (RPMI) 1640 
medium (Gibco, Invitrogen) with 50 μM 2-mercaptoethanol (Gibco, Invitrogen) and 
10% fetal bovine serum (FBS, Gemini Bioproduct), referred to as “media”. For pro-
inflammatory stimulation, the protocol from Lund et al. was followed (110). ThP-1 cells 
were differentiated with 25 nM phorbyl 12-myristate 13-acetate (PMA, Sigma) in media 
for 48 hours, which induced the cells to adhere to the tissue culture flask. After PMA 
differentiation, cells were washed with fresh media and incubated 24 hours. ThP-1 
cells were then detached using TrpLE (Thermo Fisher) for 30 min, followed by gentle 
scraping. Subsequently, cells were seeded in tissue culture plates at a density of 1 
million cells/mL in media, and given 2 h to rest. For stimulated ThP-1 cells, 
lipopolysaccharide from s. Enterica (LPS, Sigma) in PBS was added to cell cultures at 
a final concentration of 100 ng/mL, and incubated for 7 hours. An equal volume of PBS 
was added to nonstimulated cell media. Cell culture supernatants were collected and 
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centrifuged at 200 × g for 5 min to remove cells, and then frozen at −80 °C for future 
analysis. 
3.2.4. Multiplex Assay Procedure 
Sample and calibration diluents contained 9% PEG, 0.5% BSA, and 0.25% 
Tween 20 in PBS. For assay calibration, a 7-step curve consisting of 1:3 serial dilutions 
from a “high” standard were prepared. To determine assay sensitivity, a high standard 
of 1.2 ng/mL was used for each biomarker. For the analysis of cell culture samples, 
the high standard contained 12 ng/mL IL-8 and 4 ng/mL of each of IL-1β, IL-6, IL-10, 
and TNF-α. Additionally, these standards contained 10% cell media to reduce any 
potential bias in the calibration curve caused by matrix effects. Cell culture supernatant 
samples were thawed, diluted 1:10 in sample diluent just before use, and run in 
quadruplicate. 
To start the assay, calibration standards and samples were added to 
prespotted wells (80 μL per well). Plates were then sealed and incubated in the dark 
at room temperature for 4 hours. During sample incubation, spotted DEX/antibody 
mixtures rehydrate and form a stable ATPS in PEG while antigens in the sample 
partition into the droplets, allowing for parallel immunoassays in a single well. After 
sample incubation, wells were washed eight times with 0.05% Tween 20 in PBS. After 
washing, 80 μL of streptavidin-HRP (diluted from a 200× stock in PBS containing 1% 
BSA) was added to each well and incubated in the dark for an additional 20 min. After 
HRP incubation, wells were washed another four times before 100 μL of 
chemiluminescent substrate (prepared according to manufacturer’s instructions) was 
added to each well prior to plate imaging. 
For antibody diffusion experiments, wells were blocked with 1% BSA in PBS 
for 1 hour and then washed three times with PBS containing 0.05% Tween 20. 
Microbasins were spotted with 1 μL of a solution containing 1.67× StabilCoat, 10% 
sorbitol, 2 μg/mL rhodamine-labeled antibody, and 16.67% DEX and dehydrated 
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overnight. To visualize antibody diffusion, DEX droplets were rehydrated with either a 
9% PEG solution or PBS only while fluorescence images were collected at t = 0 
minutes, 15 minutes, 1 hour, and 4 hours using a ChemiDoc MP imaging system (Bio-
Rad). 
3.2.5. Singleplex Assay Procedure 
Singleplex experiments were performed using the custom-designed 32-well 
plates and the same antibody pairs as described previously. cAb solutions were diluted 
to working concentrations in PBS (concentrations as determined in titration 
experiments for the multiplex assay), and 1 μL was spotted into the center microbasin 
of each well. The plate was covered and incubated overnight at room temperature in 
the dark. Wells were then washed three times with 200 μL of PBS with 0.05% Tween 
20 for each well. Next, plates were blocked with 100 μL of 1% BSA in PBS per well for 
1 hour. After plates were washed again, 80 μL of sample was added to each well. 
Duplicate 7-step calibration curves were created, using 1:3 serial dilutions with a high 
standard concentration of 1200 pg/mL prepared in 1% BSA in PBS. Protein samples 
were incubated for 2 hours and then removed using the previously described washing 
procedure. Detection antibody solutions for each biomarker were diluted to working 
concentrations (Table A.3.1) in 1% BSA in PBS, and 100 μL was added to each well. 
After a 2 hour incubation, dAb solutions were removed, wells were washed, and 80 μL 
of a streptavidin-HRP solution (diluted in 1% BSA in PBS) was added to each well. 
After a 20 minute incubation, the plate was washed a final time, and 100 μL of 
chemiluminescence substrate was added to each well before imaging. 
3.2.6. Analysis 
A Q-View Imager LS (Quansys Bioscience) was used for plate imaging with an 
exposure time of 400 seconds. Q-View software (Quansys) was used for initial image 
collection. For image analysis, ImageJ was used to extract signal intensities from each 
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microbasin, which were used to generate calibration curves. Data was then exported 
into Prism (Graphpad) and fit to a four-parameter, variable slope curve for calculation 
of unknown samples. The limit of detection (LOD) was calculated as described in 
Armbruster et al. (112). Signal to noise ratios (S/N) are calculated by dividing the mean 
signal from the high standard (1200 pg/mL) by the mean of the blank. 
3.3. Results and Discussion 
 
 
Figure 3.2. Comparison of manual and prespotted ATPS multiplex ELISA methods. 
Black and gray diamonds represent different analytes (Ag). The hydrated ATPS 
method involves overnight cAb immobilization and sample incubation (A1) followed by 
washing and blocking steps. After the analyte has bound to the cAb, wells are filled 
with a PEG solution, and droplets of dAb/DEX are manually placed on top of each 
microbasin (A2). The dehydrated ATPS method involves a plate preparation step 
yielding preapplied and dehydrated cAb and dAb in each microbasin (B1). Sample in 
a PEG solution can then be added to wells, allowing an ATPS to be formed after the 
dAb/DEX droplets rehydrate (B2). Antigens partition from the PEG phase into the DEX 
phase and bind to available antibodies. 
 
Frampton and Simon et al. reported the first planar multiplex immunoassay 
platforms that effectively prevent reagent-driven cross-talk (18, 74). To accomplish 
this, dAb incubation was performed using a PEG-DEX ATPS water-in-water droplet 
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array format rather than the traditional bath, or cocktail, application (Figure 3.2A). 
Although this allows segregation of antibody pairs, elimination of antibody cross-talk, 
and generation of a highly reliable assay, it is tedious and difficult for a user to 
accurately place ∼1 μL dAb-DEX droplets in appropriate locations. Here, we describe 
the preparation and use of an improved ATPS multiplex ELISA procedure in which an 
assay plate with prespotted and dehydrated reagents is used to simplify assay 
procedure and reduce potential for user error (Figure 3.2B). 
For assay plate preparation, cAb was arrayed and immobilized in wells prior to 
the addition of a stabilization and blocking additive (Figure 3.3A, 3.3B). Titration 
experiments were performed to determine optimal cAb concentrations. Specifically, 
cAb concentrations ranging from 0.5 to 12 μg/mL were immobilized in microwells prior 
to performing ATPS ELISA. In these experiments, dAb and reference analyte 
concentrations remained constant (Table A.3.1). Sample results for the cAb 
optimization tests, shown in Figure 3.3H (TNF-α only), illustrate the typical trend 
observed in these experiments. Signal increases as more cAb is used because the 
polystyrene surface is not yet saturated with antibodies, and additional cAb 
immobilization allows a higher number of antigen molecules to bind. Curves reached 
an apex before a decrease in signal was observed at higher concentrations. This 
decrease in signal is likely caused by excess, nonimmobilized antibody that is 
competing with immobilized cAb for antigen binding. Titration curve apexes were used 
to determine the optimal cAb concentration for each biomarker, yielding 2 μg/mL for 





Figure 3.3. Plate preparation procedure and assay optimization results for the 
prespotted ATPS multiplex ELISA method. Panels A–G represent the different steps 
performed in a single microbasin prior to running an assay. After cAb (Y) diluted in 
PBS (gray --) is immobilized at the microbasin bottom (A), stability reagent (gray --) is 
added (B). The two solutions mix and are dehydrated under a fan (C). A layer of 
dextran and sorbitol in PBS (gray --) is added (D), which is also dehydrated, indicated 
by the change in curvature (E). The final coat (gray --) contains dAb (gray Y), sorbitol, 
and dextran (F), and dehydration occurs in a desiccator overnight (G). Sample data 
used to determine optimal cAb concentrations shows mean chemiluminescence 
signal, and the error bars are standard deviations (H). The results (showing only TNF-
α cAb titration) are exemplary for all cAb titrations performed which each show an apex 
between 2 and 6 μg/mL. 
 
The remaining steps illustrated in Figure 3.3 involve the layering of DEX and 
dAb components. Figure 3.3D illustrates the addition of a DEX solution on top of the 
cAb/StabilCoat layer. This step provides separation between the already dehydrated 
cAb and the final dAb/DEX coat to avoid premature cAb/dAb mixing and nonspecific 
binding potentially causing a decrease in assay performance. The final microbasin 
coating (Figure 3.3F), consisting of dAb and DEX, also includes sorbitol to prevent 
aggregation and retain antibody activity after rehydration (113-115). In this study, five 
spots are in each well and are rehydrated with 80 μL of a 9% PEG solution to give a 
final DEX concentration of 1.5% in the aqueous system. This combination is above the 
binodal curve of the PEG and DEX system which is normally required to form the 
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ATPS(34). After separation the volume ratio of the two phases is 11:1 for the PEG-
rich:DEX-rich phases (Figure 3.1A). 
 
 
Figure 3.4. Dried and rehydrated DEX phase retains the ability to prevent antibody 
cross-talk. In a fluorescently tagged antibody diffusion experiment (A), all microbasins 
that were spotted with rhodamine-dAb produce a fluorescence signal at t = 0. At t = 15 
minutes, rhodamine-dAb spots remain clearly visible in the wells with PEG solution 
added, while those in PBS wells are very faint. After a 1 hour incubation, no spots are 
visible in the PBS wells. Wells with PEG solution continue to show a strong, confined 
signal up to 4 hours, corresponding to the assay time for ATPS multiplex ELISA. In a 
dehydrated ATPS assay (B-1), the left microbasin contained cAb (Y), dAb (gray Y), 
and dextran, while the right microbasin contained only cAb and dextran. Antigen (gray 
⧫) binds to cAb in both microbasins (B-1, top), but signal is only generated from the 
one that included dAb (B-1, bottom). The standard multiplex ELISA assay (B-2) does 
not utilize ATPS; bath-applied dAb binds on all available antigen in either microbasin 
(B-2, top). This leads to a readout in which both cAb spots produce detectable signal 
(B-2, bottom), illustrating antibody cross-talk. 
 
A key advantage in using ATPS to perform multiplex ELISA is the elimination 
of antibody cross-talk, as previously demonstrated (18, 74). In the method presented 
here, ATPS is again used to prevent antibody cross-talk; however, one key difference 
is that components of the system are dehydrated during preparation and then 
rehydrated during the assay. To determine effects of the dehydration/rehydration 
procedure on the ability to confine antibodies to specific droplets and eliminate cross-
talk, two different experiments were designed. To confirm dAb confinement, 1 μL 
droplets of a rhodamine-labeled antibody/DEX mixture were placed in microbasins, 
dehydrated, and then rehydrated with either PBS or 9% PEG in PBS. Fluorescence 
images were then taken at t = 0 minutes, 15 minutes, 1 hour, and 4 hours (Figure 
3.4A). After 4 hours of incubation, fluorescent dAb was clearly compartmentalized 
49 
 
within rehydrated DEX droplets in wells containing PEG, and had diffused away in 
wells rehydrated with just PBS. 
To specifically confirm elimination of antibody cross-talk using rehydrated 
ATPS, adjacent microbasins in a single well were prepared with the aforementioned 
cAb/DEX/dAb layering procedure (Figure 3.3A–F). One spot contained both cAb and 
dAb/DEX, while the other included only cAb and DEX without dAb. After rehydration 
and completion of an assay, signal was only detected from the microbasin with both 
cAb and dAb (Figure 3.4B-1). When a traditional ELISA protocol was performed 
(involving bath application of dAb) using the same antibody pairs and arrangement, 
signal was produced by both microbasins (Figure 3.4B-2). These results demonstrate 
that, after rehydration of DEX, dAb remains confined within the microbasin for the 
entire duration of the assay, and any small amount of dAb partitioning into the PEG 
phase is insufficient for creating false positive signals in adjacent microbasins. 
Furthermore, signal intensity in the positive microbasin was comparable between 
ATPS and standard bath methods, despite the need for 80× more dAb by mass in the 
standard ELISA protocol. 
To test the utility of this method, quantitative analysis of five cytokines (IL-1β, 
IL-6, IL-8, TNF-α, and IL-10) was performed. This panel was chosen because these 
cytokines are involved in a variety of immune system functions, and have been linked 
to a range of diseases such as cancer (116-118), psoriasis (116, 118, 119), and 
rheumatoid arthritis (116, 118). Sample calibration data for this assay is shown in 
Figure 3.5A–E. LOD and S/N values for this new spotting procedure were compared 
to the manual multiplex ATPS method described by Frampton et al (18) as well as 
singleplex ELISA (curves not shown) for each biomarker (Table 3.1). The LOD is 
comparable between the three methods for all five cytokines in this study. A decrease 
in signal-to-noise ratio was observed for IL-1β and IL-8 using dehydrated ATPS 
compared to that of previously reported methods. The change in S/N comes from 
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increased background signal that may be the result of unwanted antibody denaturation 




Figure 3.5. Calibration data and results for analysis of cytokines in two sample diluents 
and macrophage cell culture supernatant. Calibration curves for IL-1β (A), IL-6 (B), IL-
8 (C), IL-10 (D), and TNF-α (E). Data shown are mean chemiluminescence signals 
from two replicates, and error bars are standard deviations (SDs). A comparison of 
prespotted wells filled with standard proteins diluted in 1% BSA in PBS to wells filled 
with proteins prepared in diluent containing 9% PEG shows no signal from any 
biomarker if PEG is not present (F). Results from macrophage cell culture samples 
with (black ■) and without (gray ■) LPS treatment are shown in G. IL-8 displayed a 10-
fold increase in concentration for LPS-stimulated cells compared to nonstimulated 
cells. Similarly, a 7-fold increase was observed for TNF-α, and 2-fold increases for IL-




Table 3.1. Comparison of Limit of Detection (LOD) and Signal to Noise Ratio (S/N) for 
Singleplex ELISA, Manual Multiplex ATPS, and Prespotted Multiplex ATPS ELISA 
 
  IL-1b IL-6 IL-8 IL-10 TNF-a 
LOD [pg/mL] 
singleplex 2.69 <4.94 1.02 <4.94 <1.65 
manual ATPS <1.65 1.40 1.87 2.81 0.52 
prespotted ATPS 2.05 <1.65 2.72 3.40 1.67 
S/N 
singleplex 171.9 10.8 138.7 10.4 4.1 
manual ATPS 224.8 51.9 85.5 40.2 25.3 
prespotted ATPS 64.8 30.2 19.3 16.4 7.6 
 
 
Non-ATPS multiplex assays were also attempted using identical plate layout 
and reagent amounts. For this, plates were prepared and dehydrated using previously 
described methods. Instead of rehydrating this plate with the ATPS-forming PEG 
diluent, however, we used a sample diluent consisting of 1% BSA in PBS. Resulting 
signal from this non-ATPS protocol could not be distinguished from background, 
suggesting diffusion and loss of dAbs into bulk solution. This again confirms the 
benefits of an ATPS method in providing dAb reagent savings, as a conventional, 
plate-based multiplex ELISA using these dAb amounts would not give signals. A 
comparison between signal produced from dehydrated ATPS multiplex and non-ATPS 
multiplex assays is shown in Figure 3.5F. At the time of plate imaging, 
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chemiluminescence signal is generated at HRP molecules conjugated to detection 
antibodies that have bound with antigen and are no longer free to diffuse. No ATPS is 
present at this step, and signal location and intensity represents the degree of antigen–
antibody binding. 
This 5-plex cytokine test was then used to analyze cell culture supernatant from 
LPS-stimulated human ThP-1 cells. Stimulation with LPS simulates a Gram-negative 
bacterial infection and can be used to study a pro-inflammatory response with the ThP-
1 cell line (111). Calibration data from this experiment is shown in Figure 3.5A–E, and 
results are shown in Figure 3.5G. Interestingly, data showed a 10-fold increase in IL-8 
secretion from stimulated cells compared to nonstimulated cells (Table A.3.2). 
Additionally, we observed a 7-fold increase in TNF-α levels, and a 2.5-fold increase in 
IL-10 and IL-1β in stimulated versus nonstimulated data sets. IL-6 levels also 
increased to detectable levels whereas controls were below the detection limit. Results 
from t tests (Table A.3.2) show statistically significant differences between the 
stimulated and nonstimulated samples. Importantly, the observed changes in cytokine 
levels found here complement trends found in other studies investigating LPS-
stimulated ThP-1 cells (111, 120). 
3.4. Conclusions 
In this report, we demonstrated the utility of a user-friendly multiplex ATPS-
format ELISA test for cytokines in cell culture supernatant. The formation of 
microdomains with ATPS enables compartmentalization, concentration, and storage 
of molecules. In this method, all multiplex ELISA reagents are prespotted and 
dehydrated on a multiwell plate prior to the assay, vastly reducing user pipetting steps 
at the point-of-use. The spotting of both cAb and dAb required for a sandwich assay 
exploits the benefits of an ATPS for preserving reagents in the dextran phase during 
dehydration, as well as after spontaneous rehydration during the assay. 
Although a 5-plex analysis is demonstrated here, higher plexing is possible. 
The upper limit of plexing is controlled by ATPS formation and PEG/DEX ratios, as 
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well as the ability to reproducibly create small droplets to increase the number of 
analyses per well. This method also provides significant reagent savings, as orders of 
magnitude less dAb is used per analyte compared to other multiplex ELISA platforms 
generating strong signals and comparable LODs. Although plate preparation for this 
method includes a high number of pipetting steps, droplet placement is less 
specialized, and these steps can be easily automated with a liquid handling station. 
Importantly, this technology should be applicable to a broad combination of biomarkers 
including “incompatible” combinations that show reagent related cross-talk in 
conventional ELISA where dAb is applied as a mixture or cocktail.  
Chapter adapted with permission from Eiden L, Yamanishi C, Takayama S, 
Dishinger JF. Aqueous Two-Phase System Rehydration of Antibody-Polymer 
Microarrays Enables Convenient Compartmentalized Multiplex Immunoassays. Anal 




CHAPTER 4: One-Incubation One-Hour Multiplex ELISA Enabled by ATPS 
 
4.1. Introduction 
ELISAs enable selective quantification of a variety of analytes, including small 
molecules, proteins, viruses, and bacteria, by employing an enzyme linked antigen or 
antibody as a marker for the detection of specific analytes (121). When appropriate 
antibodies are available, ELISA can provide high sensitivity and high specificity (122). 
However, this technique can involve time-consuming procedures and tedious washing 
processes. Moreover, it is normally limited to only one target at a time (122, 123). 
Contemporary studies have shown that many diseases and biological processes 
involve multiple different proteins, highlighting the need for measurement of multiple 
targets within the same sample (124-126). 
Recent advances have enabled multiplex ELISA, allowing for simultaneous 
detection of multiple targets, conserving time and reagents, thus enabling analysis of 
more complex biological processes (75, 105, 127, 128). However, the typical multiplex 
sandwich ELISA assay involves three separate incubation steps for three different 
protein-ligand interactions, as in Figure 4.1A: (i) binding of analyte to capture antibody 
(cAb), (ii) binding of detection antibody (dAb) to cAb-bound analyte, and (iii) binding of 
streptavidin-HRP to the analyte-bound dAb through a biotin-streptavidin interaction 
(129-131). Note that each incubation step is also followed by wash steps. To enable 
ELISA multiplex detection, cAbs for different targets can be arrayed within single 
microwell. However, this strategy quickly becomes susceptible to unintended cross 




Figure. 4.1. Schematic of ELISA procedure: (A) Standard ELISA for singleplex detection, (B) Two-incubation ATPS ELISA and (C) One-
incubation ATPS ELISA for multiplex detection. 
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An aqueous two-phase systems (ATPS) approach was developed previously 
to enable to protect cross-reaction in multiplex ELISA (18). Antibodies remain confined 
to their designated locations within dextran microdroplets during the detection antibody 
binding step. Table 4.1 summarizes previous reports of multiplex ELISA detection of 
cytokines by employing ATPS; assay information is given such as assay time, numbers 
of incubation, wash, material, types of plate, microbasin, working range, S/N and LOD. 
Our group previously demonstrated that these cross-reactions can be avoided by using 
ATPS to co-localize correct antibody pairs (18, 74). More recently, our group showed 
that the ATPS ELISA technique could be used with dehydrated reagents, allowing the 
dAb microarray to be in place before the user adds sample (19). In that technique 
Figure 4.1B, dAb in a dextran (DEX) solution is microarrayed over corresponding cAb-
coated microbasins followed by dehydration. Sample aliquot was diluted into a poly 
(ethylene glycol) (PEG) solution and added into the well. Water from the PEG solution 
rehydrates the DEX microdroplet, while maintaining phase separation and antibody 
confinement. Target proteins, however, are able to penetrate into the DEX phase for 
binding in the sandwich assay. Thus, the first two binding steps (i, ii) are integrated into 
one step which took 4 hours. Subsequent washing, 20 minutes incubation with 




Table 4.1. Previous ATPS ELISA method of cytokine detection (singleplex and multiplex), assay information included; assay time, numbers of 

















4 hr, 40 
min 
(Two, 9) Polystyrene, clear 
plate, clear 
microbasin 
3.91-2,000 IL-6 = 30.1 
IL-10 = 15 
TNF-α = 10.1 
IL-1β = 30.1 
IL-8 = 33.2 
IL-6 = 9.38 
IL-10 = 31.2 
TNF-α = 15.6 
IL-1β = 3.91 







15 min (Two, 9) Polystyrene, black 
plate, black 
microbasin 




2 hr N/A Polystyrene, black 
plate, white 
microbasin 
1-1,200 N/A IL-6 = 6.2  
IL-8 = 20.6  







5 hr (Two, 18) Polystyrene, clear 
plate, clear 
microbasin 
1-10,000 N/A HGF = 96  
Elafin = 1437  
ST2 = 103  






Table 4.1. (Continued). 
Multiplex  
(ATPS ELISA) 
4 hr, 20 
min 
(Two, 12) Polystyrene, clear 
plate, clear 
microbasin 
1-1,200 IL-6 = 30.2 
IL-10 = 16.4 
TNF-α = 7.6 
IL-1β = 64.8 
IL-8 = 19.3 
IL-6 = <1.65 
IL-10 = 3.40 
TNF-α = 1.67 
IL-1β = 2.05 





1 hr (One, 6) Polystyrene, black 
plate, black 
microbasin 
1-2,000 IL-6 = 30.3 
IL-10 = 10.1 
TNF-α = 27.2 
IL-1β = 43.06 
CCL18 = 
43.52 
IL-6 = 1.82 
IL-10 = 4.89 
TNF-α = 2.41 
IL-1β = 7.63 
CCL18 = 3.65 
This work 
 
*Non ATPS: This assay is for method comparison 
  N/A: Not available
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In this work, we report an additional evolution of the ATPS ELISA where the 
HRP reagent is already included in the sample PEG solution so that after pipetting 
samples to the plate pre-spotted with antibodies and DEX polymer there is only one 
washing procedure before signal readout. The plate leads to all three-binding 
interactions (i, ii, iii) occurring in a single step, 1-hour incubation, as shown in Figure 
4.1C. This procedure reduces total time for the ELISA by 5-fold, while also minimizing 
wash steps.  In addition to user convenience, this new assay maintains previously-
reported advantages of ATPS-ELISA, such as two orders of magnitude lower 
consumption of dAb and minimizing dAb cross-reactions due to ATPS confinement. 
Furthermore, through consideration of ATPS composition, we achieve favorable 
sensitivity and high assay performance compared to our previously reported method 
(19), and to singleplex methods. Another substantial improvement over our previous 
report is the use of a black rather than clear plastic microwell plates to reduce optical 
cross-talk through the plastic. Lastly, we perform analyses of THP-1 macrophage 
secreted cytokines using this convenient one-incubation ELISA and characterize M1 
and M2 polarized cells. This rapid, one-incubation ELISA moves the ATPS ELISA 
method closer to clinical utility, where it could aid in diagnosis of infections or other 
diseases (133). 
4.2. Materials and methods 
4.2.1. Chemicals and reagents 
ELISA DuoSet kits for human IL-6 (DY206), human IL-10 (DY217B-05), human 
TNF-α (DY210), human IL-1β (DY201) and human CCL18 (DY394-05) were acquired 
from R&D Systems. Each DuoSet kit contains cAbs, dAbs, antigen standards and 40× 
streptavidin-HRP. SuperSignal™ ELISA Femto Substrate (product no. 37075) was 
purchased from Thermo Fisher Scientific (Rockford, IL, USA). All cAbs were diluted in 
1×PBS pH 7.4 (10010-023) from Gibco, Life Technologies. Other reagents were 
prepared in buffers containing indicated amounts of distilled water (Gibco, Life 
Technologies, 15230-170), 5×StabilCoat (SurModics, Eden Prairie, MN, USA), DEX 
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MW 500,000 g/mol, PEG MW 35,000 g/mol, Tween 20 (Sigma, St. Louis, MO, USA), 
and bovine serum albumin (BSA) (Millipore, Burlington, MA, USA).  
4.2.2 Fluorescence image detection of FITC-dAb DEX  
for optimal conditions of one-incubation assay 
Fluorescent stereo microscope (Leica M165 FC, Leica Microsystems) was 
used for all bright field and fluorescence imaging (λex: 490 nm, λem: 520 nm). 
Investigation of conditions for one-incubation assay: selection of ATPS system (i.e. 
ATPS condition) and blocking buffer were carried out by using custom 96-well injection 
molded black plates with 1.7 mm diameter microbasins (9 per well) (PHASIQ, Ann 
Arbor, Michigan).  
Selection of ATPS condition: Investigation of FITC-dAb retention in DEX was 
studied, concentration of PEG-DEX (%w/w) is provided following; (a) 9%-9%, (b) 5%-
9%, (c) 9%-5%, (d) 5%-5%, (e) 3%-5%, (f) 5%-3% and (g) 3%-3% as shown in Fig 
1(B).  Dedicated DEX concentrations were spotted on the black plate (1uL/1 
microbasin) by (Repeater®, Eppendorf, Hauppauge, NY, USA). The plate was dried in 
desiccator for 1 hour. Next, dedicated PEG concentration were added into each well. 
After 1 hour, the plate was imaged by the fluorescence microscope.  
Selection of blocking buffer: Five types of blocking buffer (3× StabilCoatTM, 1× 
StabilCoatTM, 5% BSA, 5% goat serum, and 0.1% ChonblockTM with 0.05% goat 
serum) were spotted on the black plate (1uL/1 microbasin). The plate was dried in a 
desiccator for 1 hour. Then, 1 µL of 5% DEX was placed on dried cAb spots. After 1 
hour, the plate was imaged by the fluorescence microscope. 
4.2.3 Singleplex detection by standard ELISA procedure 
Singleplex ELISA was performed according to manufacturer instructions from 
R&D DuoSet ELISA at room temperature (25 oC). Briefly, transparent microwell plate 
was prepared as follows: 100 µL of the working dilution of cAbs was coated on each 
well of 96-well microplate and incubated overnight. The plates were washed 
sequentially 3 times with 400 μL of 0.05% Tween 20 in PBS each, then blocked with 
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300 μL of 1% BSA in PBS (1×, pH 7.4) for 1 hour. After blocking, the plate was repeated 
washed sequentially 3 times. Next, antigen standards or sample (prepared in 1%BSA 
in PBS in a two-fold dilution series) were added at 100 μL per well and the plate was 
incubated for 2 hours at room temperature in the dark. The plate was washed and 
incubated with 100 μL of appropriate dAb per well for 2-hour incubation. Following 
additional 3× washing, 100 μL of streptavidin-HRP was added to each well at the 
manufacturer’s recommended concentration and the plate was incubated for 20 
minutes in the dark. After a final wash, 100 μL of enzyme substrate peroxidase 
chromogen was added into each well. After 20 minutes of incubation in the dark, 50 μL 
of 0.18 M H2SO4 was added into each well to stop the reaction. Lastly, a BioTek 
Synergy H4 microplate reader was used to measure absorbance at 450 nm.   
4.2.4 Multiplex detection by ATPS ELISA procedure 
Two multiplex detection methods of ATPS ELISA (i.e. One-and two- 
incubations) were performed by employing custom 96-well injection molded black 
plates. Microplates were washed prior to immobilization step by spraying with ethanol 
and followed by distilled water, the washed plated was kept a desiccator for drying and 
storing until needed.  
4.2.4.1 One-incubation ATPS ELISA procedure 
Firstly, cAb were arrayed at indicated concentrations by pipetting of 1.0 L 
(Repeater®, Eppendorf, Hauppauge, NY, USA) into appropriate microbasins within 
each microplate well. The arrayed plates of cAb immobilization were covered and 
stored under dark condition at room temperature for 90 minutes. After that the plates 
were washed three times with wash buffer (i.e. 0.05% Tween 20 in PBS) to remove all 
unbounded cAb. Then, 100 µL of 5% sucrose in PBS was added into each well to block 
remaining binding surfaces and to stabilize the cAbs against denaturation during 
dehydration. After removing of sucrose, plates were dried in a desiccator for 40 
minutes to facilitate accurate microarraying in subsequent steps. To more thoroughly 
cover binding surfaces, indicated blocking buffers were arrayed into every microbasin 
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containing cAb by Eppendorf repeater pipette, followed by an additional 40 minute 
drying step. Detection antibody was prepared in distilled water with DEX with various 
desired concentrations (i.e. 9%, 5% and 3%w/w). These dAb solutions were spotted 
at 1 µL per microbasin and dried in a vacuum desiccator overnight.  Next, antigen 
standards were diluted 1:1 serial dilution between solution containing indicated 
concentrations of PEG, 0.05% Tween 20, 0.5% BSA, and indicated concentrations of 
streptavidin-HRP in PBS, along with antigen standards or samples. A 7-point standard 
curve was constructed with 2-fold dilutions from 2,000 pg/mL in triplicate. After adding 
100 µL of standard solution in each well, plate was incubated for 1 hour. And then, 
plates were washed 6 times with wash buffer to remove all unbounded proteins. These 
additional wash steps were necessary to remove viscous ATPS components. Finally, 
100 μL of the chemiluminescence substrate was added into each well before taking 
images using a BioRad ChemiDoc MP+ Western Blot reader with an exposure time of 
40 seconds. 
4.2.4.2 Two-incubation ATPS ELISA procedure 
The two-incubation ELISA was different from the one-incubation ELISA with 
the following changes. For assay procedure of two-incubation ELISA, there is no 
streptavidin-HRP in PEG solution. Thus, 100 µL of streptavidin-HRP solution was 
added into each well after 1-hour incubation. After streptavidin-HRP incubation, the 
plate was washed three times with wash buffer, filled with 100 μL of 
chemiluminescence substrate for each well as shown in Figure 4.1B. The details of 
this procedure can be found in previous report by our group (132, 134). All tested and 
optimal conditions are summarized in Table A.4.1. 
4.2.5. Cell culture and macrophage preparation 
Human monocytic THP-1 cells (ATCC, TIB-202) were grown in Roswell Park 
Memorial Institute (RPMI) 1640 biotin-free medium (MyBioSource, MBS653376) with 
10% fetal bovine serum (FBS) (Gemini Bio-products), and 1% penicillin-streptomycin 
(Gibco). Cells were seeded in T75 flasks at a density of 1×106 cells/mL, and 
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differentiated into macrophages as described by Spiller et. al. (135), with 320 nM PMA 
(Sigma) and incubated overnight. The activated and now adherent THP-1 derived 
macrophages were washed three times with fresh media to remove PMA. THP-1-
derived macrophages were then detached using Accutase (Sigma, A6964) for 5-10 
minutes at 37oC followed by gentle scraping before being collected and counted using 
a Nexcelom Cell Counter. Subsequently, macrophages were seeded into T25 flasks 
for polarization into M1 or M2 macrophages (105). Macrophages were polarized 
toward M1 by adding 100 ng/mL LPS (Sigma, L2630), and 100 ng/mL interferon 
gamma (IFN-γ) (R&D Systems, 285-IF), and incubated for 48 h. Macrophages were 
polarized toward M2 by adding 20 ng/mL IL-13 (R&D Systems, 213-ILB), and 40 ng/mL 
IL-4 (R&D Systems, 204-IL), and incubated for 48 hours. Cells were washed three 
times in cell culture medium and incubated for 24 hours to allow the macrophages to 
secrete cytokines into the supernatant. Supernatants were collected and centrifuged 
at 200× g for 5 minutes to remove dead cells and debris, then frozen at -80oC for 
subsequent ELISA analysis. 
4.2.6 Fluorescence/chemiluminescence imaging: Image J 
Image J Software (http://imagej.nih.gov/ij/) was used for evaluation of 
fluorescence intensity from FITC-dAb images and all chemiluminescence images from 
ELISA. A custom Image J plugin was written to aid in identifying and outlining 
microbasin areas within each well. Briefly, the plugin guides the user through image 
rotation and determination of the size and locations of microbasins to generate a plate-
wide map. The plugin then measured the average chemiluminescence intensity for 
each microbasin, exporting an Excel sheet with annotated wells and microbasin 
intensities.  
4.2.7. Evaluation of analytical characteristic of ELISA assay 
Standard curves were constructed and fitted with a four-parameter logistic 
function in Graph Pad Prism for calculating sample values. The limit of detection was 
calculated as LOB + 1.65 (SDlow concentration sample), where LOB is the limit of blank and 
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SD is the standard deviation. LOB was computed from LOB = meanblank + 
1.645(SDblank). Signal to noise ratios (S/N) were calculated as mean signal from the 
highest antigen standards (2,000 pg/mL) divided by mean of the blank, assuming that 
noise does not correlate with signal intensity. Coefficient of variation (CV) was 
calculated as percent of SD from antigen standard signal divided by mean of the signal. 
A t-test was performed by GraphPad InStat software (GraphPad Software Inc., San 
Diego, CA, USA) for statistical analysis (unpaired t test) between M1 and M2 (Section 
4.3.3).  
4.3. Results and discussion 
In this work, we compare three ELISA assays, as shown in Figure 4.1A-C. For 
standard ELISA (Figure 4.1A), dAb incubation is separate and follows antigen binding 
to surface immobilized cAb, resulting in more steps and longer overall assay time. The 
total assay time is 4 hours with nine washing steps. For the two-incubation ATPS 
ELISA that we reported previously Figure 4.1B, dAbs are pre-spotted reducing the 
number of steps in the assay. Our newly described one-incubation ELISA includes 
HRP in the sample PEG solution and has an optimized PEG and DEX formulation, as 
described below, that reduces the incubation time by 4-fold (1 hour) and reduces wash 
steps by half Figure 4.1C. 
4.3.1. Optimization of one-incubation ATPS ELISA 
In consideration of recent work by our group, showing that ATPS composition 
can influence mass transport within the rehydrating DEX phase (132), we examined 
ATPS composition to balance the competing factors of 1. high polymer content for high 
dAb retention in the DEX phase, and 2. low polymer content for low viscosity and 
improved mass transport. 
4.3.1.1 Investigation of ATPS conditions 
Concentrations of PEG and DEX are key parameters for ATPS ELISAs 
because they affect retention of detection antibodies in DEX phase, and in the case of 
assays that include HRP in the PEG phase, the amount of non-specific background 
65 
 
signal generated. As shown in Figures 4.2A and 4.2B, we tested seven different 
formulations of PEG-DEX concentrations to study their effect on detection-antibody 
retention. ATPS solutions of different PEG-DEX concentrations (%w/w) were; (a) 
5%PEG-5%DEX, (b) 9%PEG-9%DEX, (c) 5%PEG-9%DEX, (d) 9%PEG-5%DEX, (e) 
3%PEG-5%DEX, (f) 5%PEG-3%DEX and (g) 3%PEG-3%DEX, each ATPS condition 
was also performed with one-incubation ELISA and the calculated LODs were 1.82, 
231.11, 24.38, 30.23, 12, 96.36 and 267.28 pg/mL, respectively (Figure 4.1C. All 
fluorescence images of ATPS solution of FITC-dAb-DEX were given in Figure A.4.1). 
A majority of the goat anti-human IgG FITC-antibodies are retained within DEX phases 
over the course of 1 hour for high and medium concentration of DEX (9% and 5%w/w, 
respectively) but not at the lower concentration of DEX. Moreover, size and shape of 
DEX droplets remain consistent over this period.  
We next determined the calibration curves for a singleplex IL-6 ATPS ELISA 
using the same 7 different PEG-DEX formulations (Figure 4.2C). Low PEG and DEX 
concentration (3%) have low antibody retention in DEX (Figure 4.2) leading to low 
signal and low sensitivity as expected. The high PEG and DEX concentrations (9%) 
produced high background. Surprisingly, high PEG and DEX concentrations (9%) that 
yield high antibody retention in DEX droplets also had lower signal than the moderate 
concentrations (5%). This may be due to the high viscosity, which limits the ability of 
the analyte to interact with cAbs at the surface and dAbs in solution. The medium PEG 
and DEX concentration (5%) balanced the two competing needs of a high signal and 





















Figure 4.2. Effect of PEG-DEX concentration on FITC-dAb retention in DEX and ELISA 
reaction; (A) Bar graph for percent of FITC-dAb retaining in DEX droplets and S/N. 
PEG-DEX concentration; (a) 5%PEG-5%DEX, (b) 9%PEG-9%DEX, (c) 5%PEG-
9%DEX, (d) 9%PEG-5%DEX, (e) 3%PEG-5%DEX, (f) 5%PEG-3%DEX and (g) 
3%PEG-3%DEX The percent was measured by fraction of FITC-antibodies intensity 
in 0 minutes to 1 hour multiplying with 100 from three replicate measurements, bars 
are standard deviations (SDs). (B) Fluorescence images of FITC-dAb retaining in DEX 
droplets (C) Effect of PEG-DEX concentration on ELISA reaction. 
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4.3.1.2 Incubation time 
The typical sandwich ELISA assay involves three separate incubation steps for 
three different protein-ligand interactions: (i) binding of analyte to cAb, (ii) binding of 
dAb to cAb-bound analyte, and (iii) binding of HRP to the analyte-bound dAb through 
a biotin-streptavidin interaction. Each incubation step is also followed by wash steps. 
In our previously published multiplex ATPS ELISA assay, we integrated the first two 
binding incubations into one step which took 4 hours, followed by wash, incubation 
with HRP for another 20 minutes, another wash, and then reading chemiluminescent 
signal. In a more recent singleplex ATPS ELISA that also integrates the first two 
binding incubations, we demonstrated a formulation with enhanced internal convection 
that provided signals with just a 15 minute incubation time rather than 4 hours, although 
with slightly inferior sensitivity. For our new one-incubation ELISA, we investigated 
incubation times of 15 minutes, 1 hour and 4 hours as shown in Table 4.2. 
 
 
Table 4.2. Effect of incubation time on ATPS ELISA (15 minutes, 1 hour and 4 hours). 
The performance was carried out with information, LOD, CV (%) and S/N±SD (n=3) 






CV (%) S/N±SD 
ELISA images 
Signal Noise 
15 minutes >500 3.69% 3.74±0.03 
  
1 hour <1 1.34% 28.91±0.89 
  






We found that in our new procedure that integrates all three-binding interaction 
into one incubation with 1 hour provided an optimal time for incubation, it provided 
sufficiently high signal with low background signal that leads to high S/N and low LOD 
(see details in Figure A.4.2 and Figure A.4.3). The shorter time (15 minutes) was not 
sufficient time for strong signals to be obtained. On the other hand, a 4-hour incubation 
also did not enhance sensitivity because of a higher background signal.  
4.3.1.3. Blocking buffer 
Common blocking buffer solutions are composed of proteins, surfactants, or 
other additive compounds that minimize aggregation, precipitation, and nonspecific 
interaction of regents and analyte to surfaces. Blocking buffer can also stabilize 
antibody molecules on dried surfaces through a variety of mechanisms, including 
hydrogen bonding replacement and vitrification (136). Identification of an appropriate 
blocking scheme is critical for achieving high signal-to-noise ratios. Table 3 lists five 
types of blocking buffer for selection. 
We also determined the calibration curves for an ATPS ELISA using 5 different 
blocking buffers: 3× StabilCoatTM, 1× StabilCoatTM, 5% BSA, 5% goat serum, and 
0.1% ChonblockTM with 0.05% goat serum (137, 138). 
BSA is a commonly used blocking agents typically used at a 1 to 5% 
concentration. As displayed in Table 4.3, dehydrated 5%BSA-5%DEX generates an 
inconsistent, porous surface during dehydration that led to low repeatability and low 
sensitivity. Use of goat serum and ChonblockTM led to weak signals. StabilCoatTM 
produced dehydrated DEX spots with the smoothest surface (Table 4.3) and provided 
high repeatability in IL-6 ELISAs. The use of 3× StabilCoat provided better sensitivity 




Table 4.3. Images of dried spots employing different types of blocking buffer with 5% DEX containing IgG FITC-antibodies. A scale bar was 1000 
µm. Performing of ATPS ELISA was carried out with information, LOD, CV (%) and S/N±SD (n=3) obtained by using each blocking buffer is listed. 
 





     
Fluorescence 
images 
     
LOD 
(pg/mL) <1 26.17 95.13 69        1,660 
CV (%) 1.88 3.01 54.68 36.98        68.65 
S/N±SD 27.79±0.45 9.62±0.65 2.64±0.46 3.78±0.40 2.70±0.06 
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4.3.1.4. Capture antibody, detection antibody and HRP concentrations 
Selection of suitable concentrations of capture antibody, detection antibody 
and HRP for one-incubation ATPS ELISA was performed. 
Capture antibody concentration: To determine suitable cAb concentration to 
spot, 1 µL droplets containing 2 to 25 μg/mL of cAb (0.002-0.025 μg of cAb) were 
arrayed and the S/N of ATPS ELISA performance determined (Fig. 4.3A). Signal 
increased as more cAb was immobilized, then leveled off. Because our plate 
preparation involves a step where excess cAb is washed away prior to dAb spotting, 
higher cAb spotting does not lead to a hook effect where the S/N decreases, in contrast 
to our previous method (19). From these results, we selected cAb concentrations of 10 
ng/mL for IL-6, IL-10, TNF-α, IL-1β and CCL18.   
Detection antibody: Figure 4.3B presents a dAb concentration study to 
determine optimal dAb concentrations for improving S/N. Specifically, a concentration 
range of dAb from 1 to 75 ng/mL (0.001-0.075 ng of dAb) was tested. Curves reached 
a peak prior to reduction of S/N at higher concentrations. The decrease in S/N at higher 
dAb concentration generally resulted from high background signal. Based on these 
results we selected dAb concentrations of 10 ng/mL for IL-6, 25 ng/mL for IL-10, TNF-
α, IL-1β and CCL18. 
HRP concentration: HRP concentration plays important role to enhance S/N 
and it was tested as shown in Figure 4.3C. The key takes away is that too little leads 
to weak signal while too much leads to high background. The optimal amount of HRP 
in an assay also depends on the total amount of biotinylated dAb that is present in an 
assay microwell because the streptavidin-conjugated HRP is incubated together with 
the dAb before any excess is washed away, unlike typical protocols. Based on these 
considerations, the optimum HRP concentration was found to be 5× the manufacturer 
recommended concentration.  
 




















Figure 4.3. Determination of optimal cAb, dAb and HRP concentrations shows mean 
chemiluminescent signal, and the error bars are standard deviations; (A) cAb 
concentration (0-25 µg/mL), (B) dAb concentration (0-75 ng/mL) and (C) HRP 
concentration (1×-15×).  
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4.3.2. Comparison of ELISA performance for multiplex detection 
As an application for the newly developed one-incubation ATPS ELISA, we 
compare the ELISA performance of three procedures (see Figure 4.1A-C and Table 
4.4) with the detection of a five-cytokine panel (IL-6, IL-10, TNF-α, IL-1β and CCL18). 
These cytokines, produced by various cell types including macrophages, are important 
modulators in immune responses and diseases such as cancer, and autoimmune 
diseases (138). Identifying the cytokine profile released in cell culture supernatants 
aids in classifying cells into disease-relevant subsets, for example, M1 pro-
inflammatory versus M2 pro-regenerative macrophage populations. Therefore, the 
five-cytokine panel we developed tests typical markers for M1 (IL-6, TNF-α, IL-1β) and 
M2 (IL-10, CCL18) phenotypes. Calibration curves, LOD, and S/N for standard ELISA 
(No ATPS), two-incubation and one-incubation ATPS ELISA are shown in Figure 4.4 
for each biomarker (Table 4.4). 
LOD and S/N comparison between the three methods is shown in Figure 4.1 
(A-C) for each cytokine that was investigated. An improved LOD was observed for 
ATPS ELISA (i.e. one- and two-incubation) compared to the standard ELISA, possibly 
due to convective mixing and reagent co-localization. Table A.4.2 summarizes 
previous reports of multiplex ELISA detection of cytokines. It is shown that our method 
provides short assay time (1 hour) and high sensitivity (LOD = 1.82-7.63 pg/mL) when 
compared to other methods. 
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Table 4.4 Performance comparison of three ELISA methods (i.e. standard ELISA, two-
incubation ATPS ELISA and one-incubation ATPS ELISA). Comparison of LOD, CV 
(%) and S/N±SD (n=36) in each method for detection of five cytokines. 
 
Methods IL-6 IL-10 TNF-α IL-1β CCL18 
 LOD (pg/mL) 
Standard ELISA 




28.6 83.50 23.01 60.71 33.18 
One-incubation 
ATPS ELISA 1.8 4.89 2.41 7.63 3.65 
 S/N 
Standard ELISA 




29.7 3.2 14.25 18.60 25.97 
One-incubation 
ATPS ELISA 30.3 10.1 27.20 43.06 43.52 




5.53% 4.73% 7.53% 9.81% 8.91% 
One-incubation 
ATPS ELISA 6.64% 4.81% 6.36% 8.43% 8.84% 
 
 
4.3.3 Measurement of human macrophage cytokine production 
We optimized the 5-plex detection assay to test the application of our one-
incubation ELISA, see Table 4.5 of summarized conditions for optimization studies and 
Figure 4.4 for 5-plex standard curves. We measured the cytokine production from ThP-
1-derived human macrophages to compare the cytokine secretion of M1 and M2 
polarized human macrophages. Figure 4.5 presents the cytokine production by human 
macrophages (M1 and M2). For statistical analysis, a t-test analysis (unpaired t test) 
between M1 and M2 was performed; differences between groups were considered 
statistically significant when P < 0.01. Consistent with previous reports (111, 120, 138), 
we detected higher IL-6 and IL-1β in M1 macrophages, while IL-10 was elevated in M2 
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macrophages (P < 0.01). Both phenotypes expressed TNF-α and CCL18 at similar 
levels (P>0.05). Applying a one-incubation ELISA approach to test cytokine profiles of 
macrophage supernatants generated results in one hour; faster than commercially 
available options (5-fold total assay time reduction compared to standard method). 
Therefore, reducing washing steps significantly to achieve a one-hour incubation time 
has the potential to accelerate high-throughput observations using cell culture 
supernatants.  
 
Table 4.5  . Summary of the investigated range and selected condition for one-
incubation ATPS ELISA 
 
Variable Investigated range  Selected condition 
1. PEG-DEX 
concentration  
9%-9%, 5%-9%, 9%-5%, 5%-5%, 
3%-5%, 5%-3% and 3%-3% 
(%w/w) 
5%-5% (%w/w) 
2. Incubation time 15 minutes, 1 hour and 4 hours 1 hour 
3. Types of blocking 
buffer 
3×StabilCoat, 1×StabilCoat, 




4. cAb concentration  2, 4, 6, 8, 10, 15, 20 and 25 
µg/mL 
10 µg/mL 
5. dAb concentration  1, 10, 25, 50 and 75 ng/mL 10 ng/mL for IL-6,  
25 ng/mL for IL-10,  
TNF-α, IL-1β, and 
CCL18 








Figure 4.4 Calibration data and results for analysis of cytokines in human monocytic 
ThP-1 cells. Calibration curves for IL-6, IL-10, TNF-α, IL-1β, and CCL18. Curves 
shown are mean chemiluminescence signals from three replicates, and error bars are 
standard deviations (SDs). 
 
 
Figure 4.5.  Measurement of cytokine production by M1- and M2-polarized 
macrophage, n = 3 replicate measurements, error bars are SDs. “ns” indicates not 
significant (p>0.05), whereas “**” indicates significant difference (p<0.01) between M1 








We developed a one-incubation with one-hour multiplex immunoassay. We 
examined competing factors that influence the selection of an ideal ATPS composition 
for rehydrated, multiplex ELISA: namely antibody retention in the DEX phase, 
incubation time, selection of blocking buffer, antibody concentration, and HRP 
concentration. We characterized the signal to noise ratio and the limit of detection for 
our optimized ATPS ELISA and found improvements over our previous work. Lastly, 
we demonstrated quantification of cytokines in macrophage supernatants that are 
consistent with published literature. From a practical perspective, this assay provides 
a convenient and high sensitivity option for multiplex detection of cytokines. From the 
perspective of how to formulate ATPSs for ELISA use, this work describes a 
conceptual shift from simply maximizing antibody partitioning to optimizing the overall 
process that also includes mass transport and background signal levels. 
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CHAPTER 5 Biofabrication of phenotypic pulmonary fibrosis assays 
5.1. Introduction 
Idiopathic pulmonary fibrosis (IPF) is a devastating lung disease, in which 
normal lung parenchyma is progressively replaced with fibrotic scar tissue. Although 
the pathology of the disease is varied and still controversial, it generally involves 
dysregulation of the normal wound healing process. In a prevailing disease theory 
(139-142), an initial insult to the alveolar epithelial layer leads to recruitment of 
macrophages and other immune cells in a pro-inflammatory response Figure 5.1. The 
epithelial injury leads to clotting and fibrin formation, accompanied by fibroblast 
invasion to plug the wound. The fibroblasts then proliferate and activate (Figure 5.1). 
Activated fibroblasts, termed myofibroblasts due to the expression of alpha-smooth 
muscle actin, contract the tissue and deposit extracellular matrix (ECM) to close the 
wound. In a healthy response, the myofibroblasts would subsequently apoptose to be 
cleared by macrophages, facilitating re-epithelialization and a return to the original 
healthy state. In pulmonary fibrosis, however, the myofibroblasts become senescent 
(143) and continue to generate stiff tissue. Lung stiffening is accompanied by 
irreversible alveolar collapse, ultimately preventing breathing in patients (144).  
Treatment options for pulmonary fibrosis are sparse, highlighting the need for 
effective models of the disease (145). The standard animal model of pulmonary fibrosis 
uses bleomycin to generate scar tissue in rodents. This model yields lungs similar in 
histological appearance to fibrosis, but subtle differences from the human disease 
have led to misuse of the model (146). In parallel with animal studies, there has been 
considerable progress in development of complex in vitro models of pulmonary fibrosis 
(147). A subset of these models provide readouts of cell and tissue level phenotypes 
associated with pulmonary fibrosis. Phenotypic assays are advantageous over 
mechanistic assays, because they can account for complex, multifactorial cell 
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behaviors producing sometimes unexpected and emergent behavior. Phenotypic 
assays have proven generally useful in the discovery of first-in-class new therapeutics 
(148). In this review, we will examine and contrast a variety of biofabrication techniques 
to assess pulmonary fibrosis phenotypes in the in vitro setting. The analysis aims to 
summarize progress and highlight challenges and opportunities in this field. 
5.2. Techniques for in vitro phenotypic analysis of pulmonary fibrosis 
This review is organized by describing in vitro cell-based assays that aim to 
recreate various aspects of pulmonary fibrosis pathogenesis roughly in their order of 
progression in vivo: epithelial damage, fibroblast invasion, clotting, fibroblast 
activation, myofibroblast contraction, and myofibroblast persistence. These techniques 
are summarized in Figure 5.1, where they are sorted roughly by the phenotypes they 
cover and when those phenotypes occur in a simplified model of IPF pathogenesis. 
Table 5.1 at the end of this chapter further summarizes the techniques. 
5.2.1 Phenotypic assays incorporating epithelial damage 
In the context of pulmonary fibrosis, epithelial damage could arise from a 
variety of sources, including aging, smoking, infection, inhaled toxins or nanoparticles, 
and a variety of other potential insults (149). A common observation among IPF 
patients is telomere shortening. The telomere shortening hypothesis of disease 
pathogenesis is consistent with the strong correlation between prevalence and patient 
age. Assays of epithelial damage in the context of IPF should therefore include some 
consideration of aging, repetitive damage, or similar types of stress. Downstream 
biochemical signaling has been reviewed elsewhere (150-152), and should also be 
considered. A plethora of techniques for culturing and assaying epithelial cells exist, 
but this review will cover those assays that pertain most specifically to epithelial-
fibroblast interactions in pulmonary fibrosis. 
 




Figure 5.1. In vitro assays of pulmonary fibrosis. In a simplified model of pulmonary 
fibrosis, an epithelial injury precedes formation of the clot-like provisional extracellular 
matrix (ECM). Subsequently, fibroblasts invade the wound site and differentiate into 
myofibroblasts. The myofibroblasts accelerate wound closure by contracting and 
depositing extracellular matrix components, predominantly collagen. The assays 
covered in this review are listed and roughly sorted by the phenotypes present in each 
assay, labelled by the gray arrows. Additional information for each technique is in Table 
5.1. Note that some assays span multiple phenotypes that may split across the graph.  
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Several techniques have been developed to physically induce epithelial 
damage, the presumed first step towards development of pulmonary fibrosis. Some of 
these techniques use custom-built devices to impose cyclical strain on epithelial cells, 
similar to that seen in healthy breathing. In one iteration, alveolar epithelial cells were 
seeded onto a flexible silicone membrane, anchored with a washer (153). This 
membrane was cyclically stretched by pressing on the underside of the membrane with 
a motorized cam mechanism. The authors demonstrated that epithelial cells were 
damaged by strains of ~25%. Furthermore, additional culture time prior to cyclic strain 
had a protective effect on the epithelial cells. Another version of the technique 
comprised a stretching microdevice with flexible polydimethylsiloxane (PDMS) 
membrane and syringe pump hydraulic actuation (154). This study found that air-liquid 
interface culture exposed cells to high damage from cyclic stretching at ~35% strain. 
They also examined fluid mechanical stress from liquid plug movement, finding that 
the damage could be reduced by addition of pulmonary surfactant. These studies 
examined physiological strain, but they could be adapted to replicate the fibrotic lung, 
which is less compliant than healthy lungs. Although hyperventilation has not been 
causally linked to pulmonary fibrosis, mechanical ventilation has been shown to 
correlate with bleak outcomes for patients with pulmonary fibrosis whose hypoxemia 
prompts the use of mechanical ventilation (155, 156). These cyclic stretch models 
provide methods to assess the epithelial contribution to disease exacerbation. 
In static culture settings, membrane culture techniques, such as Transwell 
culture, have gained tremendous popularity. These devices comprise a porous 
membrane, fixed to an insert that can be submerged into a culture well, enabling 
physically separated co-culture between the membrane cell population and the well 
plate cell population (157). Transwells have also been used extensively to generate 
and test air-liquid interface (ALI) culture. ALI culture prompts many airway epithelial 
cells to differentiate into more physiologic epithelium (158). The membrane ALI format 
 
 81  
 
 
has been adapted to allow aerosol exposure to nanoparticles in well-plate format (159) 
as well as microfluidic devices (160). In addition to cell viability and biochemical 
assays, membrane cultures are amenable to measurements of epithelial barrier 
integrity. Barrier function can be measured by either permeability assays using 
fluorescently-labeled macromolecules, such as dextran (161), or using trans-epithelial 
electrical resistance (162). Transwell and membrane techniques present versatile tools 
for biofabrication of assays incorporating ALI epithelial components. 
For analysis of epithelial injury and wound healing, the scratch wound assay is 
well established (163). Briefly, a confluent monolayer of epithelial cells is denuded 
using a pipet tip or other blunt object to tear off the epithelial cells. The remaining edges 
are tracked visually as the epithelial cells proliferate and migrate to repair the wound 
area. A recent paper combined the scratch wound assay with Transwell co-culture (4), 
wherein A549 epithelial cells were grown on the top of the membrane, while primary 
human lung fibroblasts (healthy vs IPF) were grown on the underside of the membrane, 
as depicted in Figure 5.2A. The authors reported differing behavior in healthy and IPF 
patient-derived pulmonary fibroblasts. After scratching the epithelial layer, the A549 
migrated over 4 days to close the wound. In co-culture with healthy fibroblasts, the 
fibroblasts migrated into the wound site to plug the gap and inhibited re-
epithelialization. However, pulmonary fibrosis-derived fibroblasts failed to invade the 
wound site, allowing the epithelium to close the wound. This study prompts interesting 
questions about the long-term behavior of pulmonary fibroblasts in healthy and 
diseased states, as the healthy fibroblasts appeared more active in the short period 
examined than the diseased fibroblasts, contrary to what may be expected. Despite 
the progress made with biofabricated assays of epithelial damage, there remains fertile 
ground for research regarding long-term culture, chronic epithelial damage, and 
downstream signaling relevant to IPF. A particularly challenging aspect of lung 
research has been the inability to culture alveolar epithelial cells. However, recent work 
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has indicated that co-culture with pulmonary fibroblasts may help solve the problem 
(35). New biofabrication methods could provide additional benefits by working directly 
with clinicians to establish cell cultures directly from the source. 
5.2.2 Phenotypic assays incorporating fibroblast invasion 
Following epithelial damage, a coagulation cascade results in the formation of 
the provisional ECM. Fibrinogen from blood plasma is cross-linked into fibrin, which is 
supported hydrostatically by glycosaminoglycans such as hyaluronic acid (164). 
Fibroblasts from surrounding tissue then invade this provisional ECM in order to initiate 
the remodeling process. As illustrated in Figure 5.1, formation of the provisional ECM 
and invasion of fibroblasts is an early component of pathogenesis, where it develops 
as the consequence of an aberrant wound healing response (140). A number of 
techniques have been developed to recapitulate behavior of fibroblasts in the 
provisional ECM, both for evaluation of the physiology of fibroblast invasion and for 
screening of potential therapeutics.  
One such approach utilized a fibroblast-containing collagen matrix, formed on 
top of a dehydrated/rehydrated fibrin gel in media. Fibroblasts were then able to invade 
the fibrin matrix. This was used to evaluate the influence of fibronectin during fibroblast 
invasion into a fibrin matrix, and it was found that fibronectin provides a conduit for 
fibroblast transmigration from collagenous stroma into the fibrin clot provisional matrix. 
Fibroblast migration began as early as 24 hours into the assay, but was significantly 
slowed by the removal of fibronectin (165). This approach was used to further establish 









Figure 5.2. Phenotypic assays for invasion. (a) In the Transwell scratch and invasion 
assay, fibroblasts are seeded on the underside of the Transwell, while epithelial cells 
are seeded on the top side. The epithelial layer is gently scratched with a pipet tip to 
remove a section of epithelial cells. After several days of culture, epithelial cells and 
fibroblasts may migrate into the opened area (4). (b) The collagen plug covered in 
fibrin assay monitors fibroblast migration from an encapsulated collagen gel out into 
the surrounding fibrin gel (5). (c) Spheroids were seeded in agarose-coated 384-well 
microplates. Fibroblasts added after spheroid formation could be observed invading 
the spheroids (6).  
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Miron-Mendoza et al. used a similar assay to evaluate the impact of fibrin cross-
linking on fibroblast migration. Cell-laden collagen discs were coated with fibrin for an 
easily imaged cell invasion assay (Figure 5.2B). This was used to show that 
supplemental fibronectin was necessary for the invasive fibroblast phenotype, and 
fibroblast-fibronectin network formation was dependent on α5β1 integrin. Fibronectin 
tracks (fluorescently labelled) were formed at the leading edge of migrating cells and 
fibroblasts preferentially migrated through pre-existing fibronectin tracks laid down by 
other cells (5).  
Other phenotypic assays for fibroblast invasiveness have focused on migration 
from 2D adherent culture into fibrin matrices. One such approach used microdroplets 
of fibroblast suspension patterned on a 6-well plate and covered with a fibrin matrix 
(168). Through this approach, migration from the 2D culture into the fibrin gel was used 
to evaluate invasiveness of fibroblasts isolated from patients with acute lung injuries. 
This was used to evaluate the role of CD44 in mediating fibroblast invasion and 
subsequent tissue fibrosis. By blocking the function of CD44 with monoclonal 
antibodies, fibroblast invasion into a fibrin matrix was inhibited (169). 
An alternative, matrix-free approach focused on fibroblast invasion into cancer 
spheroids. This was used for evaluation of therapeutic candidates to combat fibrotic 
processes in cancer, but could just as easily be applied as a phenotypic assay for 
invasiveness in other forms of fibrosis. The approach was optimized for 384-well 
microplates for high throughput evaluation of drug libraries. Tumor spheroids were 
formed in agarose-coated wells, as depicted in Figure 5.2C. A suspension of 
fluorescently labeled fibroblasts was then added and invasiveness was evaluated via 
confocal spinning disc microscopy to locate the fluorescent lung fibroblasts that had 
invaded the spheroids. A 480-compound library of bioactive substances was evaluated 
for anti-invasiveness, where prostaglandins and ROCK inhibitors were identified as 
potential therapeutics (6).  
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Lewis et al. used a co-culture technique involving a photodegradable PEG-
based hydrogel in order to evaluate the impact of crosstalk between fibroblasts and 
cancer cells on invasiveness of the fibroblasts. An Operetta high content imaging 
machine was used for high-throughput migration tracking in order to show the 
increased invasiveness and matrix metalloproteinase (MMP) expression in fibroblasts 
under the influence of cross-talk with cancer cells compared to fibroblasts alone (170). 
Despite the involvement of the fibroblast invasion into the provisional ECM 
during fibrosis, there remains a question of whether it is necessary for the 
pathogenesis of fibrotic disease. In the case of pulmonary fibrosis, fibrin deposition 
does not itself appear to be required for pathogenesis because fibrinogen-null mice 
are still able to develop lung fibrosis after bleomycin-induced lung injury (171, 172). 
Assays based on fibroblast invasion into the provisional ECM should therefore 
establish physiological importance before being used to evaluate compound libraries 
for potential therapeutic candidates.  
5.2.3 Phenotypic assays incorporating fibroblast contraction 
A histological hallmark of IPF is the presence of fibroblastic foci, dense clusters 
of cells and ECM in the lung. The characteristic cell type in these clusters is the 
myofibroblast. These cells are a differentiated and activated form of fibroblasts, which 
synthesize collagen and contract the ECM. The myofibroblast is considered the 
primary effector cell in driving the progression of IPF (173). There are extensive 
reviews covering the various roles and behaviors of myofibroblasts (173-177). A 
plethora of biofabrication techniques have been developed to measure contraction, an 
identifying characteristic of the myofibroblast phenotype. The bulk of these techniques 
are based on collagen contraction, but there are exceptions. Tuan et al used a fibrin 
gel scaffold in their model as an analogue to the provisional ECM in wound repair. Gel 
contraction and collagen production were evaluated in order to show matrix remodeling 
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under transforming growth factor (TGF-β1) stimulation (178). The use of other hydrogel 
alternatives to collagen is already covered in detail by other reviews (147, 179, 180). 
5.2.3.1 Collagen gel contraction assay 
Collagen gel contraction is the gold standard of phenotypic readouts for 
evaluation of fibrosis, with widespread use. The first reported use of a collagen gel 
contraction assay established the standard contraction assay format in 1979 (181). 
When fibroblast-laden collagen gels are cultured in media with serum, they exhibit a 
high baseline level of contraction, shrinking gels to as small as 1/7th the original area 
within 24 hours (181, 182). The collagen gel may adhere to the walls of the dish, so 
most protocols physically detach the gel from the wall using a sterile pipet tip after 
polymerization. The need for this step limits the throughput of collagen gel contraction 
assays. These assays are often called floating collagen gels (183). The contraction 
has been divided into three phases: slow lag phase, rapid contraction phase, and 
sustained slow contraction phase (184). During the lag phase, fibroblasts recover from 
trypsinization and elongate along collagen fibers. As previously reviewed (174), tensile 
force measurements of collagen gels indicated that the lag phase correlates with 
fibroblast adhesion and cell movement within the collagen gel. Therefore, the lag 
phase has also been called the traction phase (174). The length of the lag phase can 
be shortened by using more cells, more serum, or cells at higher passage number 
(184). Following the lag phase, the collagen gel is rapidly contracted and remodeled, 
at rates sped up by high cell number or serum concentration and slowed down by 
higher initial collagen concentration or cytoskeletal inhibitors. Lastly, the system enters 
a state of slow, prolonged contraction.  
Contraction by fibroblasts is regulated to a large extent by TGF-β1 (185), which 
can be added exogenously to induce contraction (186) or produced or activated by 
fibroblasts themselves (187), among other sources (187-189). The combination of 
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TGF-β1 and tensile stress induces fibroblasts to differentiate to myofibroblasts, 
identified by their expression of alpha-smooth muscle actin (α-SMA), stress fibers, and 
high contractility (185). It should be noted that tensile stress is also a necessary and 
critical component for myofibroblast differentiation (190). The capacity for tensile stress 
within collagen gels can be increased by tethering gels to the dish (181) or altering 
gelation parameters to form stiffer gels. Gels formed at more acidic conditions down to 
pH 5.5 have demonstrated higher tensile strength than gels formed at more neutral or 
alkaline conditions up to pH 8.0 (191). Collagen stiffness can also be increased by 
using higher concentrations of collagen (192).  
Following the initial development of the collagen gel contraction assay, many 
adaptations to the format have been added. The conventional collagen contraction 
assay is low throughput and high cost, due to the large consumption of collagen and 
cells. More modern techniques enable higher throughput with drastically lower 
collagen gel volumes. In addition to the cost benefit, low volume collagen gels also 
reduce the diffusion distance necessary for media and relevant exogenous 
biomolecules (9). 
One approach to improve assay consistency is to confine the collagen gel 
within a glass capillary tube, yielding a single, linear measurement, as in Figure 5.3A 
(3). Suspended human bladder-derived smooth muscle cells in an uncured collagen 
solution were aspirated into glass capillary tubes and polymerized. The collagen gels 
were then detached from the capillary by gently applying air pressure to one end. The 
capillaries were placed in an incubator inside a petri dish alongside smaller dishes of 
water to provide supplemental humidity. Over 48 hours of culture, cell viability was 
consistent between the capillary culture method and the traditional whole well culture 
method. Due to the diffusive barrier introduced by the glass capillary, the stimulants 
and inhibitors were added to the gel prior to polymerization. Standard deviations ran 
close to 1% between replicates. The authors also suggest that the capillary technique 
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is amenable to future addition of electrical current. Although the capillary technique is 
limited to short-term culture applications due to diffusive limitations, it provides a 
consistent, easy-to-read assay that uses low volumes of collagen.  
Although fibroblasts can contract collagen gels shortly after seeding, the gel 
can often attach to the walls and bottom surface of the well, introducing inconsistencies 
when measuring and analyzing the contraction. In addition to the pipet tip manual 
detachment method, several groups have developed techniques to consistently seed 
gels that cover only a fraction of the well area, often employing non-adherent surfaces 
to further reduce friction (193).  
Sage and coworkers published a series of papers using the collagen gel 
contraction assay, with an array of techniques to reduce gel adhesion. They initially 
used agarose-coated microwells to reduce the adhesion of the collagen gels to wells 
(182). In a subsequent study, however, their group designed a water-in-oil system to 
contain the collagen gel to a small Teflon-coated area in the center of the well, as 
shown in Figure 5.3B (8). In this technique, a Teflon glass cloth was pinned to the 
bottom of a 12-well tissue culture well with a Teflon-coated washer. The pieces were 
then submerged in mineral oil. Collagen with suspended adult human dermal 
fibroblasts was then pipetted into the center of the Teflon washer ring and incubated 
to polymerize the gel. Interestingly, the authors found that as the collagen gel 
contracted, it expelled media, leaving a gel in water in oil 3-phase system. The oil and 
Teflon modified collagen gel contraction assay performed better than the conventional 
assay on multiple fronts. The gels maintained a more consistent circularity compared 
to the conventional assay, wherein gels had a tendency to adhere to the well and form 
elongated shapes, stretched tightly between the anchor points. In addition to altering 
the gel shape, the anchor points in the conventional method also prevented full 
contraction, introducing noise to the measurements.  
  
 




Furthermore, conventional assays exhibited cupping, a result of cells 
sedimenting to the bottom of the collagen gel as it cured, producing vertically 
asymmetric contraction. In the large gels, cupping can interfere with microscopy, as 
cells in the center of the gel are pulled to a higher plane than the cells at the bottom of 
the well. The pre-warmed oil facilitated more rapid polymerization, trapping cells in a 
more uniformly distributed state. In studies using platelet-derived growth factor (PDGF-
BB) to stimulate contraction and measuring the reduction of area, Sage and coworkers 
achieved standard deviations of roughly 5% between replicates. While the oil and 
Figure 5.3. Collagen gel contraction assays. (a) Soluble, cell-laden collagen is pipeted 
into glass capillary tubes. After gelation, the collagen contracts linearly, enabling easy 
measurement of contraction (3). (b) Teflon-coated surfaces contain the collagen gel, 
allowing smooth contraction without friction-induced deformations. The mineral oil 
layer helps confine the gel to the Teflon-coated contraction region (8). (c) Aqueous 
two-phase systems (ATPS) enable formation of collagen microgels without excessive 
evaporation by confining soluble collagen to a dextran-rich phase until gelation. The 
ATPS components are washed out and floating collagen gel contraction assay can 
commence (9). 
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Teflon technique provides a more uniform and consistent contraction assay, it does 
lose some of the mechanical stress that has previously been shown to be a driving 
factor for fibroblast differentiation and activation (190). The authors did not comment 
on this point. Additionally, the technique is rather low throughput and still uses large 
volume gels. Nonetheless, their study presents a compelling case for addressing 
assay consistency. The widespread availability of non-adherent microplates for 
spheroid culture provide an accessible alternative to the Teflon-coated method. 
More recently, ATPSs have been used to generate collagen microgels for 
contraction assays (9) (Figure 5.3C). Scaling down to 1 µL gels facilitates diffusion of 
stimulatory or inhibitory proteins and molecules into the center of the gel. However, 1 
µL gels evaporate during the 30 minutes collagen polymerization process, often killing 
the embedded cells. The authors used ATPS to provide an aqueous buffer against 
evaporation, while confining the collagen and cells into the 1 μL gel during 
polymerization. ATPS are phase separating solutions similar to oil-water two-phase 
systems, but both phases contain primarily water. The distinction between phases in 
this particular ATPS is the presence of immiscible polymers: PEG and DEX. 
Conveniently, many cells and proteins partition preferentially to one phase, allowing 
ATPS to be used to spatially confine cells and collagen. After the collagen gel formed, 
the PEG and DEX were washed out and replaced with culture medium, leaving a 5 µL 
cell-laden collagen gel. This technique is compatible with conventional liquid handling 
tools and imaging, making it appropriate for high-throughput studies. A follow-up study 
used the technique to produce 1 µL collagen gels and showed excellent robustness of 
the technique to assess cytotoxicity in collagen gels (194). However, the consistency 
and reproducibility of the microgel technique to assess contraction have not yet been 
established. 
Several microfluidic approaches have facilitated formation of sub-millimeter 
collagen gels, as reviewed recently (195, 196). These techniques use photolithography 
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to generate channels 10s to 100s of microns in width for precise and controlled fluid 
mixing. Flow-focusing devices introduce a collagen-containing aqueous phase into a 
stream of oil to produce microdroplets of controlled size (197). Several groups have 
utilized these device geometries to generate and cure cell-laden collagen microgels 
10s to 100s of microns in diameter (198-200). However, these studies have not yet 
examined the use of microfluidic collagen microgels in contraction assays. 
5.2.3.2 Mechanics of collagen gel contraction 
In parallel with the development of techniques for assay consistency and 
throughput, several groups have designed methods to measure more detailed 
mechanical information from collagen gel contraction assays. Liu et al. demonstrated 
the importance of substrate stiffness in pulmonary fibrosis by generating a stiffness-
gradient collagen gel using photopolymerization of polyacrylamide (201). They showed 
that fibroblasts are more active and responsive to TGF-β1 on stiff substrates and less 
active on soft substrates. The lack of fibroblast activation was also found by inhibiting 
focal adhesion kinase formation with prostaglandin E2, a metabolic product produced 
by epithelial cells that has also been shown to suppress fibroblast activation in co-
culture (202). This technique was demonstrated as both a stiffness gradient gel and a 
96-well discrete stiffness array, highlighting its versatility in probing the contractile 
phenotype of fibroblasts.  
A separate study used agarose to modulate collagen gel stiffness (203). More 
agarose yields stiffer gels, which can activate fibroblasts (201). However, the agarose 
also sterically obstructs collagen presentation to the cells, inhibiting the ability of the 
cells to cross-link and locally stiffen the matrix (203). This study indicated that collagen 
concentration can increase contractility by increasing ligand availability. The 
competing factors of agarose-to-collagen ratio and the collagen concentration allow 
fine tuning of both collagen stiffness and ligand availability. 
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Although the strength of fibroblast contraction can be inferred in relative terms 
by monitoring the shrinkage of the collagen gel, more granular mechanical information 
requires more advanced techniques. A variety of mechanical sensors and 
accompanying theoretical frameworks have been built into or applied externally to the 
collagen gels (204, 205). Harley et al. made a collagen-glycosaminoglycan scaffold by 
freeze-drying (206). The process generated somewhat uniform structures with 
repeating lattice units, allowing for single-cell microscopic measurements to be 
incorporated into a whole-gel solid mechanics model. The authors generated both 
homogeneous, isotropic structures and heterogeneous structures for comparison. 
They used an Euler model of buckling stress to determine how much force a cell must 
exert on the lattice to buckle a strut, given the strut’s thickness and the overall elastic 
modulus of the material. Depending on the thickness of a given strut, the dermal 
fibroblasts exerted contractile stress of 11 to 52 nN per cell. The authors examined 
many individual cells buckling struts of various thicknesses and found an upper bound 
of 450 nN, which the cell was unable to contract. The mode of contractile failure was 
proposed to be at the focal adhesion. While this model provides granular information 
about the mechanical stresses exerted by cells, the collagen glycosaminoglycan 
structure represents a far stiffer matrix (~5 MPa linear elastic modulus) compared to 
the healthy or fibrosis lung (1-20 kPa) (201). The analysis provided in this study could 
be adapted in future studies examining biofabricated materials with stiffness more 
relevant to pulmonary fibrosis, as well as biochemical stimuli relevant to IPF. 
Another treatment of collagen gel contraction mechanics derived a solid 
mechanics model around a cylindrical collagen disc model (207). The model assumes 
an incompressible solid with a non-linear strain-dependent elastic modulus. It uses 
linear elastic mechanics to relate the area reduction and the elastic modulus 
(measured with a nano-indentation probe) to the bulk cell contraction force. These 
calculations yielded a contractile force of 1.41 nN (baseline) to 4.15 nN (activated) per 
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human aortic adventitial fibroblast cell. The differences in substrate stiffness and cell 
type confound any comparisons between this method and the collagen-
glycosaminoglycan scaffold calculations. One drawback to this model is the 
incompressible solid assumption. Several studies cited in this review indicate the 
collagen gels lose water as they compress and decrease volume (3, 8), invalidating 
the incompressible assumption. Nonetheless, this model provides a general method 
to approximate contractile forces from area reduction measurements for cylindrical 
collagen gels. 
5.2.3.3. Strain gauge techniques 
Several techniques have been developed to measure contractile forces using 
macroscale (208) and microscale strain gauges (204). In most of these systems, cell-
laden collagen gels are formed to span between two anchors. One or both of these 
anchors acts as a strain gauge. Early methods used large electronic strain gauges, 
converting the strain (or displacement) into a change in resistance using piezoelectric 
materials (208). If the geometry and elastic modulus of the anchoring material is 
known, the force exerted by the cells can be calculated. Modern methods apply the 
same principle, but use microscale anchors and detect strain by time-lapse imaging. 
Because the force exerted by cells is relatively small, strains on the materials 
commonly used for cell culture (plastics, PDMS, etc.) can be difficult to detect. A 
common workaround forms the scaffold into tall micropillars, where the long torque 
arm and cantilever action amplifies the distance that the micropillar moves in response 
to the nN-scale cell contractile forces (204).  
Another technique to measure the contractile force of fibroblasts used 
supersoft PDMS to generate microposts inside donut-shaped wells, as shown in Figure 
5.4A (2). Although hydrogels and other supersoft materials can be produced, these 
materials often suffer from tearing during demolding in traditional replica molding 
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techniques. The supersoft PDMS technique addressed the problem by using ‘hard 
candy’ recipes to generate sacrificial replica molds (2). This technique enabled 
fabrication of PDMS microwells with 200 µm diameter microposts and an elastic 
modulus on the order of 0.1 kPa. Fibroblast-laden collagen gels were centrifuged into 
the microwells, where they formed a ring around the post. When the fibroblasts 
contracted, they squeezed the post. Solid mechanics analysis enabled the calculation 
of contractile force on the post by measuring the reduced post area. The authors 
reported the force exerted as a bulk radial stress and did not calculate a per-cell force. 
The authors also demonstrated the ability to detect an initial contraction, apply an 
inhibitor, then see the cells and the post relax back toward its original shape, 
demonstrating the elastic compression.  
 
 
Chen et al. modified the tethered collagen gel format to work at the microscale, 
as shown in Figure 5.4B (7). They tested epithelial cells by treating the cells with multi-
walled carbon nanotubes (MWCNTs) in the culture flask prior to seeding in the 
Figure 5.4. Microfabricated devices for fibroblast contraction. (a) Cell-laden collagen 
gels are formed inside of microfabricated, supersoft, donut-shaped wells. The cells 
are able to contract and deform the low elastic modulus pillars (2). (b) Cell-laden 
collagen gels are seeded around micropillars. When the cells contract, the micropillars 
bend as predicted by cantilever solid mechanics (7). 
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microdevice. Cells were then suspended and seeded into the microdevices along with 
type I collagen by centrifugation. The microtissues formed and detached from the outer 
walls within 12-24 hours, with cultures lasting for 1 week without detaching from the 
micropillars, due to their goblet shape. The authors found that low concentrations of 
MWCNTs increased contraction force, while high concentrations inhibited contraction 
force. The low dose conditions corresponded to a state of inflammation and activation, 
indicated by contraction, presence of reactive oxygen species (ROS), and miR-21 
expression. The high dose caused considerable cell death, offsetting the activation, as 
measured by the contraction force. This study demonstrates the need for multifactorial 
analysis of phenotypic screens, as counteracting influences may confound the 
interpretation of results. In this case, measurement of both cell activation (contraction 
force and ROS production) and cell viability elucidated the behavior along a dose-
response curve that indicated peak bulk pathologic behavior at a medium 
concentration. 
The same group used a similar approach to evaluate anti-fibrotic therapeutics 
using their in-vitro assay (209). Fibroblasts were suspended by micropillars in a super 
thin (35 - 55 um) collagen layer arranged in a leaflet shape in order to mimic the 
geometry of alveoli. Contractile forces in the collagen were measured by deflection of 
the micropillars that suspended the collagen and differentiation of fibroblasts into 
myofibroblasts was confirmed by staining for α-SMA. This assay was then used to 
evaluate the therapeutics Nintedanib and Pirfenidone through measurement of both 
changes in tissue compliance and differentiation of fibroblasts into myofibroblasts. This 
paper also used an alternative implementation of the micropillar supported collagen 
membrane to evaluate traction bronchiectasis. By modulating the rigidity of the 
micropillars, it was shown that increased stiffness in lung tissue due to fibrosis would 
compound lung damage as seen in traction bronchiectasis. 
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Figure 5.5. Epithelial cells are seeded on top of a fibroblast-laden collagen gel in a Transwell insert. After 
confluence is reached, culture media is removed from the top well, generating an air-liquid interface 
culture. The epithelial layer differentiates in response to the air-liquid interface. After stimulation, the 
collagen gel contracts, separating from the walls of the well (1). 
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5.2.3.4 Co-culture collagen gel contraction assays 
The interplay between epithelial cells and fibroblasts may be a key component 
of pulmonary fibrosis pathology (141). In an early study, A549 or bronchial epithelial 
cells were seeded directly on top of fibroblast-laden collagen gels (210). Compared to 
the fibroblast monoculture, the co-culture gels showed less total contraction over 15 
days. The authors fit an exponential decay curve to the area reduction, finding that the 
co-culture gel had the same time constant as the monoculture, despite the differences 
in total contraction. Furthermore, the authors used two-photon microscopy to show that 
co-culture decreased the degree of collagen crosslinking, as inferred by two-photon 
fluorescence intensity. 
In another co-culture study, Ishikawa et al. prepared a similar collagen 
contraction gel with human bronchial epithelial cells seeded directly on top of the gel. 
However, this study also introduced air-liquid interface culture, as depicted in Figure 
5.5 (1). These gels were not manually detached and remained in place for 21 days 
before stimulation. The gels detached by cell contraction when cells were stimulated 
with TGF-β1. Histology slices of the microtissue demonstrated that TGF-β1 also 
induced a decrease in epithelial layer thickness. Immunostaining in these histological 
slices also revealed changes in MMP and tissue inhibitor of metalloproteinase (TIMP) 
expression due to the crosstalk between co-cultured cells. These techniques 
demonstrated the synergistic effects often seen in co-culture approaches. 
The biochemical mechanisms of epithelial-fibroblast co-culture have been 
reviewed (150). Growing evidence indicates that epithelial cells secrete a variety of 
biochemical signals to regulate fibroblast behavior. Biofabrication of phenotypic IPF 
assays would benefit from consideration of this cross-communication. 
5.2.3.5 Alternative techniques to measure fibroblast contraction 
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A recently developed technique enables measurement of cell contraction 
based on the cell coverage of the culture surface. The xCELLigence platform uses 
electrodes patterned on the surface of a culture plate to measure the electrical 
impedance past the cells (211). As the cells contract, they tighten and narrow, 
exposing electrode surfaces. The exposed surfaces pass current more easily, as the 
resistance from the cells is removed. One of the key benefits of this technique is its 
rapid response time. However, that may be more useful in studies of rapid contraction, 
as seen in muscle and cardiac tissues rather than the progressive contraction typically 
observed in fibrosis.  
5.2.3.6 Discussion of contraction assays 
As the key effector phenotype of IPF, considerable progress has been made to 
develop biofabrication techniques assessing contraction. However, one key phenotype 
that is missing from these cell-based contraction assays is the divergence between 
physiological contraction, which resolves, and pathophysiological contraction, which 
persists and progresses. The standard collagen gel contraction assay moves only in 
the direction of contraction, with little consideration or potential for reversal. The ability 
of epithelial cells to delay activation and contraction of fibroblasts (1) presents a 
promising building block for future biofabrication of assays that reflect IPF resolution. 
5.2.4 Phenotypic assays incorporating collagen production and deposition 
In addition to collagen contraction, the production and deposition of new 
collagen by fibroblasts is a key event in disease progression. A study of kidney 
mesangial cells in 2D culture indicated that they respond to TGF-β1 by forming 
clusters, or nodules, that somewhat resemble the nodules seen in human pulmonary 
fibrosis (212). Immunostaining of these nodules indicated localized deposition of 
collagen. The nodule assay was later adapted in several different publications, one of 
which used the assay to screen Chinese herbal medicine extracts for inhibition of 
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kidney fibroblast nodule formation (213). Another similar study found that 
macromolecular crowding with dextran sulfate causes much higher collagen deposition 
by fibroblasts (214). Neutral macromolecular crowding with Ficoll produces less 
elevated, but more sustained collagen deposition with greater cross-linking. Collagen 
deposition was assessed and screened using immunochemical staining and optical 
microscopy of the cluster formation. This 2D method lacks the complex 
microenvironment of some of the other techniques, but it does provide disease-
relevant information by assessing the collagen deposited by the fibroblasts. 
5.3. Future directions and conclusions 
Considerable progress has been made in the past two decades to biofabricate 
complex 3D lung culture environments that recreate aspects of pulmonary fibrosis. 
These extend from epithelial damage, to fibroblast invasion, contraction, and 
deposition. Furthermore, some of these techniques have been adapted and applied to 
medium-throughput phenotypic screens for potential therapeutics.  
However, there remains unexplored territory, particularly in the areas of 
provisional extracellular matrix and long-term disease progression. These two areas 
present particularly challenging aspects for cell-based assays. Clotting is a complex 
process involving many different factors from blood. Incorporation of endothelial 
compartments or fibrin assays has somewhat addressed the issue. Recent literature 
implicates aging and fibroblast senescence as key differences between fibrotic and 
healthy tissue in both animal models (215) and in human patients (216). The role of 
senescence in fibrosis has been reviewed recently (143). Maintaining long-term culture 
has proven difficult, although multicellular systems has shown some success, including 
the direct contact epithelial-fibroblast culture that lasted 21 days (1). Furthermore, we 
have deliberately neglected the ever-present immune system in this review. The exact 
role of the immune system in IPF remains controversial and the challenges 
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surrounding biofabrication of immune components are immense, but new work in this 
area could have tremendous benefits. 
Development of future phenotypic assays should carefully consider the unique 
features of the lung environment: mechanical compliance, tissue geometry, and the 
composition of cells and matrix proteins. Furthermore, selection of appropriate 
readouts will be critical to answering the right questions about disease progression. If 
the assays are to be adapted to high-throughput screens, then extensive optimization 
of the reproducibility and performance of the assay should be performed. 
Biofabrication of culture models that enable phenotypic screening of pulmonary fibrosis 
presents a compelling approach to finding new therapies in pulmonary fibrosis and 
potentially other related aberrant wound healing diseases.  
 
Chapter adapted from Yamanishi C, Robinson S, Takayama S. Biofabrication 




Table 5.1. Biofabricated phenotypic assays for pulmonary fibrosis. 
Technique  Cell types used Exogenous materials Scale 
Additional 
equipment Phenotypes Ref 
Scratch wound 





Rat alveolar epithelial 




Cam motor, gasket 
setup Cell death (153)  
Alveolar epithelial 
stretching damage 
Mouse alveolar epithelial 










Transwell co-culture SAEC and endothelial Transwell 6-well None Protein expression...? (157) 
Transwell with 
aerosol exposure A549 
Transwell with 1 











A549, human normal 













A549 and fibroblast 
(NHLF vs IPF) 
Transwell with 8 
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Table 5.1 (continued). 
Technique  Cell types used Exogenous materials Scale 
Additional 
equipment Phenotypes Ref 
PDMS micropillar 
tethered collagen gel 





in 35 mm 
dish 
Microfabrication Contraction (7) 
Fibroblast invasion 
from collagen into 
fibrin 
Human adult dermal 
fibroblasts 
Dried fibrin gels, 
collagen, 
fibronectin 
24-well None Invasion (166) 
Fibroblast invasion 
from 2D into fibrin 
gel 
Isolated human lung 
mesenchymal cells 
Fibrinogen, 
thrombin 6 well plate 
inverted phase 

















T47D (breast cancer), 
MCF7 + H1299 (lung 
cancer), HPF (pulmonary 
fibroblasts) 
480 compound 
library 384 well 
agarose for non-
adherent surface for 
spheroid formation 
invasiveness (6)  
2D nodule formation 
assay 
Many different cells 
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Table 5.1 (continued) 
Technique  Cell types used Exogenous materials Scale 
Additional 
equipment Phenotypes Ref 
Floating collagen gel 
contraction 
Human foreskin 
fibroblasts monoculture Collagen 
100 – 500 





NB1RGB normal human 
dermal fibroblasts Collagen 12-well 
Flexcell 




derived smooth muscle 
cells 
Glass capillary 48-well None Contraction (3) 
Supersoft micropost 
lithography 







reduction (2)  
Teflon and oil 
lubrication 




















Direct contact ALI 
with collagen gel 
contraction 
IMR-90 human fetal lung 
fibroblasts, normal 
human bronchial 
epithelial cells (HBECs) 
Collagen 12-well None Gel contraction (1) 
Electrical impedance  
Human primary bronchial 
smooth muscle cells 





MP instrument Contraction (211) 
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Table 5.1 (continued) 
Technique  Cell types used Exogenous materials Scale 
Additional 
equipment Phenotypes Ref 
Nano-indentation 




Human aortic adventitial 








Normal and diseased 
human and calf skin 
fibroblasts 





via strain gauge 
(208) 
Microfluidic droplet 
generation 3T3 fibroblast cells 
porcine gelatin, rat 
tail collagen type I 
1 nL gels, 
continuous 
production 
Blue LED for 
photocrosslinking, 
microfabrication 





Normal primary human 
lung fibroblasts (WI-38) 
Macromolecules 








Microfabrication lab None (199)  
Agarose-embedded 
collagen gels 
U373-MG human glioma 
cells Collagen, agarose Not clear None Contraction (203) 
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CHAPTER 6 Kinetic Analysis of Label-Free Collagen Gel Contraction Using 
Machine Learning-Aided Image Analysis 
 
6.1 Introduction 
Pulmonary fibrosis is a deadly lung disease, characterized by an aberrant wound 
healing response (140). Although progress has been made in understanding disease 
mechanisms, effective therapies have not yet been shown (217). Part of the difficulty in 
studying pulmonary fibrosis arises from the complex interplay between different cell types, 
mechanics, genetics, and the microenvironment (140, 142, 152, 218). Phenotypic assays, 
which can measure more holistic responses than gene or protein expression assays, are 
an important, complementary set of tools to understand cell and tissue processes (134). 
One of the classic phenotypic assays for pulmonary fibrosis is the collagen gel 
contraction assay (181). In this assay, fibroblasts are embedded into a collagen gel, which 
is detached from the surface of its container – usually a microplate well. Activated 
fibroblasts remodel the collagen gel, macroscopically shrinking the gel in a process similar 
wound closure. Despite the assay’s utility and reliability in cell lines, the behavior of 
primary lung fibroblasts can be more subtle and difficult to detect (219-221). These 
differences arise, as primary cells have variable initial states and sensitivities to 
stimulation. Primary cells present additional challenges, as they have limited growth 
capacity. Furthermore, the throughput has previously been low, as the collagen gel 
contraction assay traditionally requires the user to manually detach the gel from the edges 
of the well with a pipet tip (181). Measurement of the contracting area has also been 
manual, with pictures taken daily and images traced by hand. To address these issues, 
we explore methods to increase the throughput of the assay and incorporate continuous 
imaging. Our lab has previously developed a high throughput collagen microgel bioprinting 
technique and demonstrated its effectiveness with cell lines (9). In this assay, evaporation 
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of the microgel during curing is prevented by mixing the collagen and cells with an aqueous 
solution of DEX, which forms an ATPS with an aqueous solution of PEG. Collagen mostly 
remains within the DEX phase as it cures (222), while the PEG phase provides an aqueous 
buffer, containing the collagen and limiting evaporation. In this study, we extend the ATPS 
collagen bioprinting technique and examine contraction kinetics of normal vs diseased 
primary human lung fibroblasts, particularly in the context of anti-fibrotic drugs. 
6.2 Materials and Methods 
6.2.1 Cell Culture 
Normal human lung fibroblasts (NHLF, lot 655309) and idiopathic pulmonary 
fibrosis human lung fibroblasts (IPF, lot 627840) were purchased from Lonza 
(Walkersville, MD). These primary cells were cultured in complete Fibroblast Growth 
Medium (FGM-2, Lonza) and used from passages 2-5. For collagen gel contraction 
assays, cells were passaged into FGM-2, without serum or FGF (FGM-SF), then seeded 
into collagen gels the following day at ~75% confluence. 
6.2.2 Collagen Microgel Contraction Assay 
Collagen microgel contraction assays were seeded as previously described (9). 
96-well round bottom microplates were filled with 100 μL per well of 6% (w/w) PEG, MW 
35,000 dissolved in serum-free DMEM (Gibco) with 10% distilled water (Gibco) to adjust 
for osmotic pressure. This plate was warmed to 37C in a 5% CO2 incubator. A collagen-
detxran mixture was prepared on ice, consisting of 6% (w/w) DEX T500, 2 mg/mL Type I 
bovine skin collagen (Advanced Biomatrix), and 5 mM NaOH to neutralize the collagen. 
This mixture was mixed by pipetting up and down on ice, with care taken to avoid 
introducing bubbles. The mixture was kept on ice while cells were prepared for seeding. 
Cells were washed with PBS, then trypsinized with 0.25% Trypsin (Gibco). After the cells 
lifted, the cells were quickly diluted in FGM-SF and centrifuged at 200xg, 5 min, room 
temperature. After aspirating the supernatant, cells were resuspended in 1 mL FGM-SF 
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and counted. Appropriate volumes of resuspended cells were centrifuged again and 
resuspended in DMEM. The cells were then mixed 1:1 with the collagen mixture to 
generate a 1 mg/mL collagen, 3% DEX solution. The collagen-DEX-cell suspension was 
transferred to a 96-well plate for seeding, where the DEX-cell suspension would be 
seeded into the wells containing PEG, as in Figure 6.1.  
 
 
Figure 6.1. Schematic of ATPS collagen micro-gel contraction assay 
 
6.2.3 Liquid Handling 
A Cybi-FeliX liquid handler was used to transfer 5 μL of the collagen-DEX-cell 
suspension into the microplate containing PEG solutions. The microgels were incubated 
at 37C in a 5% CO2 incubator for 30 minutes to cure the gels. After curing the gels, all 
wells in the microplate were washed simultaneously using the liquid handler. Gel washes 
were performed by withdrawing down to 25 μL to avoid pipetting the gel, then adding and 
removing 50 μL PBS (4x) to remove PEG, then 4x more with FGM-SF, and finally refilled 
to 100 μL with a 2x concentrated solution of the desired stimulant in FGM-SF. To avoid 
withdrawing the microgels, aspiration and dispense speeds were set to 5 μL/s. 
Collagen microgels were incubated and imaged using an Incucyte in-incubator 
microscope system. 4x brightfield images were acquired at 1-hour intervals for 2 days, 
then at 6-hour intervals for the next 6 days. 
6.2.4 Drug Response Studies 
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Cell-laden collagen microgels were stimulated with or without 10 ng/mL TGF-β1 
(R&D Systems) and anti-fibrotic drugs: Nintedanib (Selleck Chem), Pirfenidone (Selleck 
Chem), and the focal adhesion kinase inhibitor PF 431396 (Tocris) at specified 
concentrations. These collagen microgels were imaged over 8 days to monitor contraction. 
To determine the half maximal inhibitory concentration (IC50), the AUC of the area over 
time graph was calculated for each individual gel as a parameter of overall contractility. 
These values were normalized, such that a gel with no contraction would have a 
normalized AUC of 100%. The IC50 was determined to be the concentration of an inhibitor 
at which the normalized AUC was halfway between the corresponding inhibitor-free 
control and 100%. IC50 determinations were considered for stimulated NHLF and 
unstimulated IPF, as the IPF are highly contractile independent of TGF-β1 stimulation. 
6.2.5 Wash Efficiency Measurements 
To assess the removal of ATPS reagents, fluorescent molecules were used. PEG 
solutions were spiked with 1 ng/mL fluorescein. The average fluorescent intensity per field 
of view was measured using the Incucyte prior to and after washing the collagen gels with 
the automated liquid handler to determine how much fluorescein, and by proxy, how much 
PEG was removed. To asses removal of DEX from the collagen gels, 1 μg/mL FITC-DEX 
MW 500,000 was spiked into the collagen-DEX-cell mixture and seeded into the PEG 
plate in separate wells. Again, the average fluorescent intensity per field of view was 
measured using the Incucyte before and after washing.  
6.2.6 Cell Viability 
Cell viability was measured using a Calcein AM, ethidium homodimer LIVE/DEAD 
stain (ThermoFisher). 1 μM of Calcein AM and 1 μM of ethidium homodimer in PBS were 
added to the collagen microgels and incubated for 1 hour. Fluorescent images were then 
acquired and quantified using the built-in Incucyte software. 
6.2.7 Image Processing 
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Collagen microgel areas were quantified using three methods: manual, Incucyte, 
and trainable WEKA segmentation. For manual quantification, gel perimeters were traced 
using ImageJ and areas were measured. For Incucyte quantification, images were 
segmented using the built-in Incucyte 2019A segmentation software from the Spheroid 
Module. In the trainable WEKA segmentation plugin from FIJI (ImageJ), 1-10 
representative microgel images were annotated and used to train the classifier. We wrote 
a new plugin to iterate through a folder of images exported from the Incucyte 2019A 
software, apply the WEKA classifier, run quality checks, measure areas, and generate a 
.csv file containing areas, well positions, and times.  
6.3 Results and Discussion 
6.3.1 Optimization of Automated Seeding and Culture 
Initially, the introduction of air bubbles into the collagen gels was problematic. 
Visual examination of the PEG plate and the collagen-DEX-cell solution indicated that 
neither were the source of bubbles. We then suspected that the relatively high viscosity of 
the collagen-DEX-cell solution was causing the solution to have delayed flow into the pipet 
tips, pulling a small pocket of air after the tip was lifted out of the seeding solution. That 
air pocket was then trapped when the pipet was introduced into the PEG solution, 
producing a bubble along with the microgel. This was confirmed by withdrawing additional 
fluid into the pipet and serially seeding multiple gel plates. Each plate contained 1-2 
bubbles per gel. To address the problem, we programmed the liquid handler to pre-
dispense 0.5 μL above the surface of the PEG, then submerge the tip into the PEG solution 
and dispense the remaining 4.5 μL. No satellite gels were introduced using this method. 
Initial tests indicated that parts of the collagen microgels were being aspirated 
during the washing step. To address this issue, the liquid handler was programmed to 
aspirate and dispense at the outer edge of the well. Subsequent imaging indicated that all 
of the microgels survived washing intact with washes performed at the outer edge of the 
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well and 5 μL/s pipetting speed. Despite the low pipetting speed measurements of 
fluorescein in the PEG solution indicated a 98% reduction in background-subtracted 
fluorescence by washing. In contrast, DEX proved more difficult to remove. Microgels 
seeded with FITC-DEX had only a 14% reduction in background-subtracted fluorescence 
immediately following washing. However, there was a 72% reduction in background-
corrected fluorescence 24 hours after the washing step. This is likely due to the low 
diffusivity of high molecular weight DEX in collagen. Note that the cells retained 94% 
viability after seeding and washing (n=3, SD=1%). 
6.3.2 Validation and Optimization of Machine Learning Image Processing 
To quantify collagen microgel area, we initially examined the built-in Incucyte 
segmentation software. However, the software performed poorly with microplate 
imperfections and gels at early time points, when they are relatively translucent. We next 
examined WEKA Trainable Segmentation, a machine learning plugin included in the open 
source image processing program, FIJI (ImageJ). Figure 6.2 shows the process for 
training the WEKA Segmentation classifier. After loading an image sequence into FIJI and 
selecting Trainable WEKA Segmentation, the background area is manually identified with 
the cursor and marked as Class 1. Gel areas are similarly marked as Class 2. After training 
a classifier, additional annotations can be added to revise the classifier until it performs 
adequately. Once a satisfactory classifier has been found, it is saved for future use. 
 
 




Figure 6.2. Training the classifier for WEKA Segmentation. 
 
 
Figure 6.3. Applying trained WEKA Segmentation to measure gel areas. 
 
To analyze large sets of images exported from the Incucyte in-incubator 
microscope, a FIJI plugin was written. This plugin uses the built-in Trainable WEKA 
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Segmentation plugin to apply the saved classifier to each image in a directory, as in Figure 
6.3. Following classification, the image was converted to binary and the largest particle 
was found using the built-in particles function. Areas and metadata were then recorded. 
During initial testing on an Intel® Core™ i7-7700 CPU at 3.60 GHz, classification 
of a single image took 15 s. Further exploration revealed that smaller training sets enabled 
faster classification. The iterative training process in Figure 6.2 allowed for fine-tuning 
small training sets to achieve accurate segmentation without sacrificing speed.  
To validate the automated image analysis algorithm, 300 images of microgels from 
early and late time points were manually annotated for comparison of area measurements. 




Figure 6.4. Correlation plot of WEKA Segmentation and manual area annotation. 
 
6.3.3 Collagen Microgel Contraction Kinetics 
We examined the performance of the ATPS collagen microgel contraction assay 
with NHLF and IPF responses to TGF-β1 stimulation at high dose (10 ng/mL) using our 
automated seeding, washing, and image processing system. The NHLF had slower 
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baseline and activated contraction compared to IPF. TGF-β1 induced a moderate increase 
in the rate of contraction for both cell types, as shown in Figure 6.5. 
 
 
Figure 6.5. Contraction of NHLF and IPF in response to stimulation with 10 ng/mL TGF-
β1. Error bars are standard error of the mean, n=15 per condition. 
 
 
To assess the potential of this assay as a platform for high-throughput drug 
discovery, we calculated the Z statistic. The Z statistic compares the variance of an assay 
to the difference between the means of positive and negative controls. A perfect assay Z 
statistic is 1.0, an excellent assay is 0.5-1.0, a good assay is 0.0-0.5, and anything below 
0 may not be appropriate for high-throughput screening. We calculated a Z statistic for 
each individual time point, as well as for the area under the curve for each individual gel, 
using 10 ng/mL TGF-β1 with NHLF as the negative control (no inhibition) and no TGF-β1 
with NHLF as the positive control. With these controls, the Z factor increases over time, 
peaking at -0.7 near day 4 (Figure 6.6). To aggregate the time course data, we also 
calculated the area under the curve of the area vs time graph for each collagen microgel. 
The area under the curve mimics the best performing individual time point, but does not 
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cross into the range of a useful high-throughput screening tool with this set of controls. 
Therefore, this assay is inappropriate for use as a primary high-throughput screening tool. 
 
 
Figure 6.6. Z Factors for set time points. The Z Factor was calculated for aggregate data 




A close examination of the individual gels demonstrates why this assay would be 
inappropriate for high-throughput screening of drug candidates. Although the mean area 
is markedly different between +/- TGF-β1 controls, individual microgels at the outer ends 
of the population distribution overlap, generating false positives and/or false negatives in 
a screen of unknown drugs, despite the stark differences between populations that are 
seen when using the industry-standard reporting method of mean +/- standard error of the 
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mean. The standard error of the mean can be an appropriate metric when addressing 
population-wide differences, but it does not convey the variance of the population. 
 
 
Figure 6.7. Contraction of individual collagen microgels. 
 
6.3.4 Examination of Anti-Fibrotic Drugs 
We next assessed the ability of known anti-fibrotic drugs to inhibit contraction of 
collagen microgels. Using a concentration range of 32 nM to 500 μM, we assessed the 
dynamic contraction of collagen microgels with NHLF and IPF cells, both with and without 
10 ng/mL TGF-β1. Consistent with literature reports (221), Pirfenidone has little effect 
below 500 μM, but mildly inhibits contraction at 500 μM in all conditions, as in Figure A.6.1. 
None of the concentrations of Pirfenidone tested produced a half maximal inhibition of 
contraction (Figure 6.8). 
In contrast, Nintedanib exhibits a dose-dependent inhibition of contraction in all 
conditions (Figure A.6.2). Areas of collagen microgels were normalized to their initial area. 
Interestingly, the inhibition of microgel contraction was largely independent of TGF-β1 for 
both NHLF and IPF. After a rapid initial contraction, the area reduction dramatically slowed 
after ~1 day in culture for both cell types. Recent reports indicate that Nintedanib acts 
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through multiple mechanisms, including inhibition of early TGF-β1 signaling, inhibition of 
extracellular matrix production, and induction of autophagy (223). Nintedanib 
demonstrated greater potency on the stimulated NHLF (IC50 = 10 μM), compared to 
unstimulated IPF (IC50 = 90 μM). This is consistent with Nintedanib’s known mechanism 
of action as a pan-kinase inhibitor (223). Furthermore, Nintedanib is known to only slow 
the progression of IPF, rather than restoring function. IPF cells, many of which are already 
activated into myofibroblasts, are not contracting in response to the same signaling 
pathway as NHLF, which is also consistent with a lower efficacy of Nintedanib for these 
cells. 
Lastly, the focal adhesion kinase (FAK) inhibitor, PF 431396, inhibited contraction 
at concentrations above 4 μM for all cell types, as shown in Figure A.6.3. Although FAK 
inhibition is not a widely used drug target, due to many off-target effects, this experiment 
does corroborate previous reports indicating that NHLF contraction of collagen gels 
requires FAK stimulation. Unlike Nintedanib, the FAK inhibitor displayed a similar efficacy 
for inhibiting contraction of IPF cells (IC50 = 10 μM) compared to NHLF (IC50 = 9 μM). 
These results are consistent with the need for mechanical stimulation via FAK signaling 
to achieve myofibroblast activation (201, 202). 
These are, to our knowledge, the first reports of dose response for inhibition of 
TGF-β1 stimulated collagen gel contraction of primary human fibroblasts by Pirfenidone, 








Figure 6.8. Dose response curves for fibrosis inhibitors on TGF-β1 (10 ng/mL) activated 
NHLF (left side) and untreated IPF collagen microgels. The normalized area under the 
curve is plotted against the drug concentration in μM for each drug in solid blue lines. The 
corresponding control is plotted in the black dotted line. The halfway point between the 
control and 100% (no contraction) is plotted in the dashed lines.  
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6.4 Conclusions and Future Directions 
We have extended the ATPS microgel contraction assay with live-cell imaging to 
uncover differential phenotypic behavior. We developed and validated liquid handling 
protocols to avoid introduction of bubbles and to remove PEG from the microgels. DEX, 
however, remains in the microgels. We assessed and optimized an automated image 
segmentation algorithm using WEKA machine learning to measure the area of each 
collagen gel with high temporal resolution. Characterization of the assay revealed that it 
is inappropriate for high-throughput screening, due to its low Z Factor. However, the assay 
still provides added convenience and throughput, making it appropriate for secondary 
screening assays and dose response studies. Lastly, we report dose response 
characteristics for two FDA approved drugs: Nintedanib, Pirfenidone, as well as the FAK 
inhibitor, PF 431396 with TGF-activated normal and non-activated IPF primary human 
fibroblasts. These results confirm previous reports of lower potency for Pirfenidone relative 
to Nintedanib. This assay could provide useful medium-throughput, phenotypic 
information to aid secondary and tertiary drug screens, as well as relatively high-
throughput information about primary cell behavior in basic research on fibroblast 
contraction.  
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CHAPTER 7: Conclusions and Future Outlooks 
 
 In this thesis work, I examined applications of ATPS for two microassays: ELISA 
and the collagen microgel contraction assay. To uncover internal micro-convection, I 
designed and built a stigmatic microscope to track 3D micro-scale flow. This microscope 
required optical modeling to determine parameters such as lens strength and ideal 
placement of components. Following construction of the microscope, I wrote software to 
calibrate and retrieve Z-positions based on the shapes of microbead images.  
 Future work using the stigmatic microscope could follow three primary routes. First, 
improvements to the microscope and software could include the addition of motorized 
focus and stage movement that are standard in many microscopes. The frame rate of the 
stigmatic microscope, as currently constructed, is also a limitation. Fine tuning the match 
between the bead tracer fluorophore and the filter cube set could increase signal, enabling 
higher temporal resolution. Furthermore, deep learning may improve the fidelity of the 
calibration, as well as processing speed. Secondly, there are further questions to be 
answered regarding the drivers of internal micro-scale convection. Comparison of flow 
tracking data to computational modeling could test the influence of Korteweg Forces that 
are assumed to drive flow. Thirdly, there are many alternate applications where micro-
scale flow is useful. Z-directional flows in microfluidic devices have proven difficult to 
measure and currently require complicated microfabrication strategies. Stigmatic 
microscopy could address some of these problems, as it only requires one viewing angle.  
I aided in the development of a pre-dried multiplex ATPS ELISA, showing that 
micro-scale confinement of reagents is robust to dehydration and rehydration. This 
enables automation of the microarray generation, unlocking the ATPS ELISA as a useful 
multiplex immunoassay. Combining the pre-dried ATPS ELISA with my findings from the 
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stigmatic microscope, I led a group to determine optimal parameters for the ATPS ELISA, 
improving the limit of detection, while also decreasing assay time and steps.  
Future work with the ATPS ELISA could examine other phase-forming 
combinations, besides PEG and DEX. These include PEG-salt systems, polyvinyl alcohol, 
and Ficoll. Additionally, the ATPS microarray assay could be combined with bead-based 
detection applications to separate known cross-reacting pairs, while drastically increasing 
the number of targets that can be detected. Pre-dried ATPS may also prove useful in cell 
migration assays, as an alternative to scratch-wound assays. 
 In a separate branch of studies, I determined the performance characteristics of 
an ATPS collagen micro-gel contraction assay. In that process, I automated most of the 
production and maintenance of the micro-gels, as well as the image analysis. This 
facilitated the use of high temporal resolution. Furthermore, this collagen microgel 
contraction assay enabled drug dose response studies, wherein I confirmed that 
Nintedanib has higher potency than Pirfenidone.  
 Future work using the collagen microgel contraction assay could explore additional 
properties of the collagen microgels. In particular, mechanical tension and collagen fiber 
alignment are known to influence fibroblast behavior. Further characterization of the 
mechanical properties could reveal insights into drug mechanisms or key differences 
between normal and IPF fibroblasts. Additionally, internal convection of ATPS collagen 
microgels could generate collagen fiber alignment, with potential applications in cancer 
migration. The automated collagen microgel assay is also amenable to long-term studies 
of sequential collagen gel contraction. Fibrosis is known to be an aging-related disease. 
In this proposed assay, cells have the opportunity to activate and differentiate into 
myofibroblasts, then act upon a fresh layer of collagen gel. Unlike mice, which are 
prohibitively expensive at long time points, this assay would enable testing of large 
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libraries of compounds that may influence aging-related fibrotic behavior. Finally, the 
collagen gel contraction assay currently contains only fibroblasts. Co-culture with epithelial 
cells presents an interesting suite of questions regarding tissue-level behavior.  
  
 





Figure A.1.4.  Model of stigmatic microscope.  (A)  Schematic.  (B)  Point-spread function 
(PSF).  (C)  Modulation transfer function with and without the toroidal lens.  (D)  Aberration 
ray fan plot showing astigmatism.  (E)  Aberration contribution from each surface in the 
microscope and a sum of the aberrations at the end.   
 





Figure A.1.2. Phase diagrams for PEG-DEX and PEG-Ficoll systems. Circles indicate 
solutions used to fit tie-lines to the binodal curves based on measured volume ratios. 
  
 




Figure A.1.3. Vertical magnitude of flow traces within the 15-minute rehydration of 1 μL 
DEX droplets with 100 μL of PEG solutions. 
 
 




Figure 3.1. (A) Custom-made 32-well polystyrene plate. Each well contains a 3x3 array of 
microbasins for droplet placement. (B) Alignment of the five biomarkers in each well was 
consistent across the plate and between different runs for the multiplex ATPS ELISA.
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Table A.3.1. Summary of dAb and high protein standard concentrations used in 
cAbtitration experiments. dAb was pre-spotted as the final layer before dehydration in 
theATPS multiplex ELISA. High protein standards were prepared in sample diluent 
andincubated for 4 hours in duplicate for each cAb concentration.  
 
Sample IL-1β IL-6 IL-8 IL-10 TNF-α 
dAb (ng/mL) 200 50 20 75 400 
Protein 
(pg/mL) 




 127  
 
 
Table A.3.2. Summary of calculated average concentrations and standard deviations 
(SD)for five biomarkers in ThP-1 cell culture supernatant with (+LPS) and without (-
LPS)stimulation. Analysis performed on pre-spotted ATPS multiplex ELISA with 4 
hourincubation of quadruplicates for each sample. Concentrations interpolated in 
Prism(GraphPad). P-values determined with two-tailed t-test.  
 
Sample IL-1β IL-6 IL-8 IL-10 TNF-α 
+ LPS 16.75 pg/mL 4.560 pg/mL 969.1 pg/mL 39.83 pg/mL 91.30 pg/mL 
SD=±1.69 SD=±2.95 SD=±156.0 SD=±9.160 SD=±10.68 
- LPS 7.210 pg/mL N/A 100.2 pg/mL 14.42 pg/mL 12.51 pg/mL 
SD=±1.190 N/A SD=±22.38 SD=±7.410 SD=±15.21 











Figure A.4.1 FITC dAb retention studies in different concentrations of PEG and DEX over 







 129  
 
 








































Figure A.4.2. Signal and noise for different incubation time (15 min, 1 hr and 4 hr) 
  
 




Figure A.4.3. ELISA with different types of blocking buffer 
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Table A.4.1 Summary of the investigated range and otimum condition for one-incubation 
ATPS ELISA 




2. Incubation time 15 min, 1 hr and 4 hr 1 hr 
3. Types of blocking 
buffer 
3xStabilCoat, 1xStabilCoat, 5%BSA, 
0.5%Goat serum and 
0.1%Chonblock/0.05%goat serum  
3xStabilCoat 
4. cAb concentrationa 
(µg/mL) 
2-25 10 
5. dAb concentrationb 
(ng/mL) 
50-400 10 ng/mL for IL-6 
25 ng/mL for IL-10, 
TNF-α, IL-1β and 
CCL18 
6. HRP concentrationc 1x-15x 5x 
acAb: Capture antibody 
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Table A.4.2. Literature performance for cytokine detection  
 






Plex LOD (pg/mL) S/N Ref. 
General ELISA 4 hours 40 min 9 3.91-2,000  1 
IL-6 = 9.38 
IL-10 = 31.2 
TNF-α = 15.6 
IL-1β = 3.91 
IL-8 = 7.81 
 
IL-6 = 30.1 
IL-10 = 15 
TNF-α = 10.1 
IL-1β = 30.1 
IL-8 = 33.2 
Commercial 




20 min 12 1-1,200  5 
IL-6 = <1.65 
IL-10 = 3.40 
TNF-α = 1.67 
IL-1β = 2.05 
IL-8 = 2.72 
 
IL-6 = 30.2 
IL-10 = 16.4 
TNF-α = 7.6 
IL-1β = 64.8 
IL-8 = 19.3 
(19) 
Two-incubation 
ELISA 15 min 9 31.25-2,000  1 IL-6 > 31.25 - (134) 
Two-incubation 
ELISA 1 hr 6 1-2,000  5 
IL-6 = 28.60 
IL-10 = 83.50 
TNF-α = 23.01 
IL-1β = 60.71 
CCL18 = 33.18 
 
IL-6 = 29.7 
IL-10 = 3.2 
TNF-α = 14.25 
IL-1β = 18.6 
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Table A.4.2 (continued). 
One-incubation 
ELISA 1 hr 6 1-2,000 5 
IL-6 = 1.82 
IL-10 = 4.89 
TNF-α = 2.41 
IL-1β = 7.63 
CCL18 = 3.65 
IL-6 = 30.3 
IL-10 = 10.1 
TNF-α = 27.2 
IL-1β = 43.06 









Figure A.6.1. Contraction of primary human fibroblasts with addition of Pirfenidone. Areas 








Figure A.6.2. Contraction of collagen microgels by primary human lung fibroblasts with 
addition of Nintedanib. Areas of collagen microgels were normalized to their initial area. 








Figure A.6.3. Contraction of collagen microgels with primary human lung fibroblasts and 
the FAK inhibitor, PF 431396. Areas are normalized to the initial area of each microgel. 
N=1-2 per condition. 
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